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ABSTRACT OF THE DISSERTATION
Identification and characterization of novel astroviruses
by
Stacy Renee Finkbeiner

Approximately 1.8 million children die from diarrhea annually, and millions
more suffer multiple episodes of nonfatal diarrhea. Despite the availability
of improved molecular diagnostics to detect the known viral agents, the
etiology of a large proportion of diarrheal cases is unknown. In fact, it is
estimated that no causative agent can be identified in up to 40% of
sporadic cases or in gastroenteritis outbreaks. Detection of novel or
unexpected viruses is the first step in identifying agents that could
potentially close the diagnostic gap and pave the way for the
development of more comprehensive preventative measures and better
treatments.
This dissertation encompasses the first application of cutting edge
mass sequencing approaches to the analysis of viruses present in fecal
specimens from patients with diarrhea. Known enteric viruses as well as
multiple sequences (with only limited sequence similarity to viruses in
GenBank) from putatively novel viruses were detected in pediatric
sporadic diarrhea specimens. One virus, Astrovirus MLB1 (AstV-MLB1), was
fully sequenced and determined to be a highly divergent, novel astrovirus
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based on phylogenetic analysis. AstV-MLB1 was further detected by RTPCR in 4/254 fecal specimens collected at the St. Louis Children’s hospital
in 2008, indicating that AstV-MLB1 is currently circulating in North America.
A second highly divergent, novel astrovirus, Astrovirus VA1 (AstVVA1), was identified in two specimens from a gastroenteritis outbreak at a
child care center. Mass sequencing yielded nearly the entire genome of
AstV-VA1 which appears to be most closely related to astroviruses found
in mink and sheep. One additional sample also tested positive for AstVVA1 by RT-PCR, resulting in detection of the virus in 3/5 specimens
collected from the outbreak.

This presents the possibility that further

investigations might reveal that AstV-VA1 is a causative agent of
gastroenteritis outbreaks.
The identification of two novel astroviruses in fecal specimens from
children with diarrhea suggests that astroviruses may cause a larger
fraction of diarrhea cases than previously recognized. Furthermore, the
identification and characterization of novel astroviruses MLB1 and VA1
lays the foundation for future investigations into their potential roles as
etiologic agents of diarrhea.
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Chapter 1: Introduction

Portions of this chapter will be published in “New Virus Discovery in the 21st
Century.” Molecular Microbiology: Diagnostic Principles and Practice. ASM Press
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Background on detection of novel viruses
The detection of novel viruses has traditionally relied heavily on the
ability to culture viruses in a laboratory setting. This has limited our ability to
detect a large number of viruses due to the fact that many viruses do not
grow well, or at all, in cell culture. Of the ones that do grow in cell culture,
it is often a tedious process to determine a permissive cell line(s) in
combination with the optimal culturing conditions that allow a virus to be
successfully propagated. Furthermore, the ability to culture a virus does
not inherently lead to easy identification or characterization of the virus. In
the past, the identification and characterization of unknown viruses grown
in culture was based primarily on visual inspection of viral particle size and
morphology using electron microscopy (EM) or serological cross reactivity
with antibodies to known viruses. The ability to determine the viral family to
which a given virus belongs to based on EM observations is severely
hampered by the fact that many viral families exhibit similar morphologies,
making it difficult to easily distinguish between them. Serological assays
also have their limitations in that the unknown virus must cross react with a
known virus for which there are serological reagents available. It also
requires having some a priori knowledge about the possible identity of the
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Figure 1.1: Methods for virus discovery in the past 20 years

unknown virus, since screening has to be done individually for each viral
family.
Since the advent of the polymerase chain reaction (PCR) in the
1980s, PCR has become a common method for detecting viral genomes.
Once the genome sequence for a given virus is available, it is a
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straightforward endeavor to design primers that detect the target virus.
Application of PCR to highly conserved regions of a given virus family or
taxa has enabled the identification of many novel viruses related to
known viral families, much as PCR targeting 16S ribosomal genes in
bacteria has resulted in the identification of novel bacteria. While the
cases of viruses discovered in this fashion are too numerous to
exhaustively list, some notable examples include sin nombre virus (Figure
1.1A) [1] and human coronavirus HKU1 [2]. Various computational
strategies for design of consensus PCR primers for novel virus identification
have been described [3,4]. However, one fundamental limitation of PCR
assays, which is shared with serological approaches, is that the breadth of
these assays is limited to interrogating a single taxa, typically a given viral
family. Thus, one must have some idea of which viral family or families one
wants to examine, which can be a daunting task given the abundance of
possibilities.
As a consequence of these limitations, other methods not subject to
this form of bias, such as representational difference analysis (RDA) [5],
have been applied to virus discovery. This method is a form of subtractive
hybridization involving the hybridization of nucleic acids between
putatively infected samples and carefully chosen controls (uninfected
samples). Unique sequences present only in the infected specimens are
preferentially amplified during subsequent PCR cycles leading to
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dramatic enrichment for the unique sequences.

The most notable

application of RDA to date resulted in the identification of human
herpesvirus-8 in Kaposi’s Sarcoma lesions (Figure 1.1A) [6]. Following this
landmark event in the use of molecular methods for virus discovery, many
other efforts to use RDA to identify novel viruses ensued, but generally with
only limited success.

In one recent successful case, RDA was used to

identify viral sequences from the novel murine norovirus 1 following serial
passage of a putative infectious agent in mice lacking innate immunity,
which effectively served to amplify the virus to much higher titers in vivo
[7].

A major technical limitation is that it is difficult to obtain a well

matched negative control for the specimen of interest, and frequently the
amplified differences between the samples reflect differences in host
gene expression rather than foreign microbial sequences.
Another landmark discovery, that of hepatitis C, relied upon a
unique strategy that combined both molecular cloning techniques with
serological methods [8]. In cDNA library immunoscreening (Figure 1.1A),
nucleic acids were extracted from putatively infected specimens and
used to generate bacterial cDNA clones. Serum from a patient suffering
from non-A, non-B hepatitis was used to screen the cDNA clones to
identify polypeptides that were bound by serum antibodies. One reactive
clone was identified that contained an insert that was not present in
control samples. Furthermore, the sequence of this clone did not hybridize
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to host sequences, suggesting that the clone represented sequence
unique to the infected sample. Sequencing of the clone yielded a new
member of the Flavivirus family, hepatitis C virus.

While this technique

identified the etiologic agent of non-A, non-B hepatitis, its application to
other diseases has been limited, and no other significant viruses have
been identified to date using this approach.

The 1st decade of the 21st century:

the Dawn of Sequence based

Discovery Methods
Sequence-independent PCR strategies and new technologies such
as microarrays and mass sequencing, while not without their own
limitations, circumvent many of the limitations associated with traditional
virus discovery methods and consequently have revolutionized the
process of virus discovery. These approaches, which can be applied
either alone or in concert with traditional methods such as tissue culture,
have enabled unbiased and massively parallel analysis of the nucleic
acid composition of a given specimen. It must be emphasized however,
that these approaches complement and do not replace traditional
virologic methods.

For example, recent discoveries of viruses, such as

Chapare hemorrhagic fever virus [9] and Melaka virus, a zoonotic bat
virus associated with respiratory disease [10], continue to demonstrate the
effectiveness of culture and serological methods. However, it is clear that
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there are viruses that do not grow in culture or that are so highly divergent
that they are not amenable to traditional methods but can be unveiled
by these newer molecular methods.

In this review, we will focus on those

viruses where molecular methods have played a critical role in their
discovery.

Sequence-independent PCR amplification strategies for virus detection
PCR screening for novel viruses using primers designed to
conserved features of viral families offers a powerful approach to virus
identification, provided there is adequate rationale to select a given
candidate viral family to test.

In the absence of a logical set of

candidates to screen, it is typically not feasible to target every viral family
individually, which would be prohibitively laborious, time-intensive, and
reagent intensive. The development of methods in which nucleic acids
could be amplified in the absence of primers designed to a specific
target sequence has played a critical role in the latest methods for virus
discovery.

These sequence independent methods are capable of

increasing the quantity of an unknown agent to detectable levels.
Various post amplification detection strategies have been devised to
‘visualize’ the products of interest that include gel electrophoresis based
differential display approaches (e.g. VIDISCA), hybridization to pan viral
microarrays, and high throughput mass sequencing.
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Identification of human metapneumovirus. The discovery of a novel
human pneumovirus in 2001, called human metapneumovirus (hMPV),
relied upon a sequence independent PCR approach in conjunction with
viral culture to identify a previously unknown virus. [11]. In this study, 28
serologically related, but otherwise unidentifiable viruses were isolated in
cell culture from patients with respiratory tract infections. One of the virus
isolates grown in cell culture was amplified using a technique called
arbitrarily primed PCR [12,13]. In this technique, primers such as the
commonly used Universal M13, T7, and T3 primers are arbitrarily selected
for use in amplification. The amplification scheme involves low stringency
annealing in the early cycles so that mismatches will be accommodated
during the annealing of the primers to many different sequences in the
sample. In the later cycles, a higher stringency annealing temperature is
used

in

which

amplicons

that

can

be

efficiently

amplified will

predominate and create a fingerprint of the sample. The fingerprint,
consisting of various sized amplicons, can then be compared to control
samples in order to identify the unique PCR products to then be
subsequently sequenced. In the case of hMPV, 10/20 PCR products that
were sequenced had amino acid similarity to avian pneumovirus (APV).
Upon further sequencing, it was determined that this novel virus encoded
proteins that were 52-87% similar to avian pneumovirus at the amino acid
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level. Preliminary animal studies showed that hMPV was able to replicate
and cause mild upper respiratory symptoms in monkeys, but did not cause
any symptoms in birds nor showed any signs of replication. Finally, the
seroprevalence of hMPV was shown to be 100% by age 5. As a result of
numerous follow up studies [14], it is now believed that hMPV is a
significant cause of respiratory tract infections. It is interesting to note that
the initial report of hMPV also noted that hMPV has been circulating in the
human population for at least 50 years, but that it eluded detection
because it did not grow well under typical cell culturing conditions, it had
low nucleotide similarity to known viruses, and lacked apparent
serological cross reactivity with antibodies generated against other viruses.

Viruses identified using DNase-SISPA. Another approach known as
sequence-independent single primer amplification (SISPA) [15] involves
the ligation of a common primer binding sequence to both ends of cDNA
molecules, which can then be amplified with a cognate primer. A
refinement of this approach called DNase-SISPA involves the treatment of
samples with DNase prior to nucleic acid extraction

[16]. The theory

behind DNase-SISPA is that the DNase should degrade host DNA, but viral
nucleic acid should be protected by the protein capsid and for some
viruses also by the lipid viral envelope. Therefore, nucleic acids that survive
the DNase treatment step should be enriched for sequences of viral origin.
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In the initial description of the method, the extracted nucleic acid was
digested using restriction enzymes and the resulting restriction fragments
were then subjected to SISPA. The SISPA products were visualized by gel
electrophoresis and prominent bands were sequenced. Amplicons
derived from novel bovine parvoviruses were identified in this initial proof
of concept (Figure 1.1B). Subsequently, DNase-SISPA has been used to
identify novel viruses from human plasma (parvovirus 4 (PARV4) and two
TTV-like anelloviruses [17]).

PARV4 has since been detected in human

serum in multiple studies, but its role in human disease is not currently
known.

In addition, application of DNase-SISPA to tissue cultures

inoculated with human stools has led to identification of the novel human
adenovirus 52 (HAdV-52) [18] and a novel cardiovirus, Saffold virus (SAF-V)
[19]. Multiple other studies have since demonstrated that viruses related
to Saffold are circulating in the human population [20-22]. The fact that
novel viruses from multiple different viral families have been identified with
this approach highlights its utility as an unbiased means for viral discovery.

Viruses identified using VIDISCA. Another approach called VIDISCA,
which stands for Virus-Discovery-cDNA-amplified restriction fragmentlength polymorphism, was used in the discovery of a novel human
coronavirus, NL63 (HCoV-NL63), in 2004 (Figure 1.1B) [23]. Like DNase-SISPA,
the VIDISCA method begins with a viral enrichment step that entails
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centrifugation to remove residual cells and mitochondria and then DNase
treatment to degrade non-enveloped or non-encapsidated DNA. Upon
RNA extraction, double stranded cDNA is synthesized and then the cDNA
is digested with restriction enzymes that are known to cut frequently
occurring DNA sequences so as to generate smaller amplifiable
sequences. Two different adapters are ligated onto the cDNA fragments
so that only sequences which have a different adapter on each end can
be subsequently amplified. To clearly visualize the products following gel
electrophoresis and compare the products to those obtained from a
control sample, another round of amplification reactions is carried out in
which the adapter primers are modified to include one extra random
nucleotide. Since one random nucleotide is added to each primer, there
are a total of 4 variations of each of the two different adapter primers
that can be used in 16 primer pair combinations to amplify subsets of the
original pool of amplicons.

Bands present in the experimental sample

lanes that are absent in the controls are excised from the gel and
sequenced.
The first application of VIDISCA to virus discovery resulted in the
identification of human coronavirus NL63 (Figure 1.1B). An unidentified
virus was propagated in tertiary monkey kidney cells after inoculation of a
nasopharyngeal aspirate from a patient with respiratory infection.
VIDSCA was performed on the supernatant from the infected cells and a
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cell culture supernatant from uninfected cells was used as a negative
control. PCR bands that were specific to the virus infected sample and
not present in the uninfected control were then sequenced. The initial
fragments shared limited sequence identity to known coronaviruses.
Subsequently, the full genome of a novel coronavirus was sequenced that
shared on average 65% identity to its closest relative HCoV-229E.
Furthermore, HCoV-NL63 contained unique genomic features, such as an
insertion in the spike protein, which is involved in receptor binding and is
thought to determine the tropism of the virus. In the original study, HCoVNL63 was also detected in up to 7% of patients with respiratory disease. A
follow-up study suggested that NL63 is associated with croup [24]. Shortly
following the identification of NL63, yet another coronavirus, HKU1, was
discovered using degenerate PCR screening strategy [2].

The

identification of these two human viruses immediately following the SARScoronavirus outbreak of 2003 has greatly increased awareness of the role
of coronaviruses in human disease, and suggested that the importance of
coronaviruses as etiologic agents of respiratory infections and their
diversity has been vastly underestimated. VIDISCA has also been used to
identify a new strain of human parechovirus type 1 [25].
These examples used sequence-independent PCR assays followed
by selective sequencing of a subset of “unique” PCR products and have
highlighted how powerful unbiased approaches are in the discovery of

- - 12 - -

novel viruses. In many ways, these techniques provide the foundation for
the higher-throughput techniques that will be discussed in the rest of this
chapter.

Sequence independent PCR followed by microarray hybridization for virus
discovery
DNA microarrays first emerged in the mid 1990s as powerful tools to
measure gene expression or genomic content changes in various
organisms

[26-28].

While

many

flavors

of

microarrays

exist,

the

commonality to all microarrays is that a high density of DNA probes,
numbering from thousands to hundreds of thousands, is attached to a
surface or surfaces enabling the analysis of complex mixtures of input
nucleic acid [26-28] in a single assay.

Capitalizing on the inherently

massively parallel nature of microarrays, Wang et al. described in 2002 the
first microarray designed to detect large numbers of viruses [29].

This

prototype DNA microarray (the “ViroChip”) harbored 1,600 70mer
oligonucleotides derived from 140 different virus species with an average
of ~ 10 oligonucleotides per virus species. Conventionally, microarrays
had been designed primarily with probes from a single organism of
interest. The rationale for development of this microarray was twofold: (1)
the microarray would enable simultaneous screening for hundreds to
thousands of known viruses in a single assay, thus making it an ideal
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diagnostic tool; (2) by careful selection of highly conserved sequences, it
was anticipated that novel viruses related to known virus families could be
detected.
Experimentally, viral nucleic acids extracted from clinical samples
are subject to random PCR amplification, fluorescently labeled and
hybridized to the microarray. The resulting hybridization patterns observed
between the nucleic acids in the sample and the oligonucleotides on the
array can be analyzed to identify whether a known or novel virus is
present in the sample. The performance of the ViroChip was validated on
both cultured viruses as well as on clinical samples. It was demonstrated
that a wide variety of viruses could be detected by the array, including
representatives of both RNA and DNA viruses [29]. With the development
of

this

technology,

it

quickly

became

apparent

that

objective

computational approaches for analysis and interpretation of the raw
microarray data were needed.

In 2005, the first algorithm for objectively

interpreting microarray hybridization data to infer the presence of
microbial species, E-predict, was described [30].

In one follow-up study,

the ViroChip detected known viruses in 53/82 (65%) nasal lavage samples
whereas only 14 (17%) of these samples yielded viruses by culture [31]. In
another follow-up study, the ViroChip demonstrated sensitivity in the
range of 85-90% and specificity of ≥99%, as compared to virus specific
PCR/RT-PCR reactions for respiratory syncytial virus, influenza and rhinovirus
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[32].

These results demonstrated the feasibility of using sequence

independent PCR amplification of clinical specimens in combination with
microarrays to detect a broad range of known viruses.

Critically, in

contrast to traditional screening strategies, a priori assumptions regarding
the types of virus present do not need to be made.
DNA microarrays using long (70mer) oligonucleotide probes have
also proven to be more robust to viral mutations than conventional PCR.
For example, in one case, ViroChip analysis indicated that a patient
specimen contained human metapneumovirus even though multiple
assays using metapneumovirus PCR primers were negative.

Sequencing

of the virus present in the sample ultimately revealed that mutations
present in the primer binding sites were most likely the cause of the false
negative PCR result [33]. This case illustrates two features of microarray
based diagnostics: (1) depending on the length of the microarray probe,
varying degrees of mutation can be tolerated, enabling detection of
variant species; (2) the presence of multiple oligonucleotide probes for
each target virus (i.e. redundancy) provides greater opportunities to
detect variant viruses.
The field of diagnostic microarrays has grown tremendously in the
past few years, with multiple broad-range diagnostic microarrays
described [34-37]. These have utilized a multitude of different microarray
platforms, probe design strategies, and oligonucleotides of varying
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lengths, demonstrating the robustness of the general methodology. In
parallel, there has been more limited progress in the development of
algorithms for interpretation of diagnostic microarrays [38,39].

The

published applications of these diagnostic microarrays to date have
focused exclusively on detection of known viruses.

By contrast, the

second goal in development of the ViroChip was to facilitate the
discovery of novel viruses.

To date, this approach has been used to

identify a number of novel viruses, from humans and animals.

Identification of SARS-CoV. The World Health Organization (WHO)
issued a global alert in 2003 regarding an illness described as “severe
acute respiratory syndrome” (SARS) that was emerging in Southeast Asia
with significant mortality.

A WHO coordinated collaboration was

established between labs around the world to try and identify the
causative agent of the highly contagious illness that had rapidly spread
from Asia to other parts of the world. This was the first case in which a DNA
microarray was employed to detect a novel virus (Figure 1.1B). The then
unknown virus was cultured in Vero cells [40]. Extraction of total nucleic
acids from the culture followed by random amplification and hybridization
to the ViroChip [41] yielded a significant signal intensity from just a few
oligonucleotides derived from the viral families Coronaviridae and
Astroviridae. Given the limited number of oligonucleotides that were
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hybridized to the sample, it appeared that there may have been two
novel viruses present in the sample. However, further analysis revealed
that all of the oligonucleotides derived from the Astroviridae family came
from a genetic element that is found in the 3’ untranslated region of the
genomes of both viral families [42]. Therefore, based on the nature of the
hybridization pattern, it appeared that a single virus, likely a coronavirus,
was present in the sample.

Since only a small subset of the highly

conserved probes from the family Coronaviridae were bound by the virus,
it was reasoned that the virus was likely to be highly divergent. In order to
rapidly sequence parts of the novel virus genome, cDNA fragments
derived from the unknown virus were physically recovered from the
surface of the microarray, PCR amplified, cloned, and sequenced.

The

largest clone contained a ~1.1kb fragment that had 33% amino acid
identity to a protein derived from murine hepatitis virus, a mouse
coronavirus, thus confirming that the SARS-CoV was a novel virus. The
coalition of scientists collaborating on the SARS effort was then able to
show

that

SARS-CoV

specific

antibodies

could

be

detected

in

convalescent-phase serum from SARS patients and that SARS-CoV RNA
could be detected in respiratory specimens. This strongly suggested that
SARS-CoV was in fact the etiological agent of the SARS outbreak
[40,43,44].
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Identification of XMRV. The ViroChip has also been applied in the
search for novel human tumor viruses, which lead to the 2007 discovery of
a novel human retrovirus in a subset of prostate cancer patients carrying
mutations in the RNase L gene [45]. Germline mutations in RNase L have
been reported to confer an increased susceptibility to prostate cancer
[29,46-48]. It was also known that such mutations were also linked with
hereditary prostate cancer, which is defined by having 3 or more
affected family members and is often recognized by the early onset of
the disease[49]. However, there were conflicting reports based on casecontrolled studies regarding the involvement of the RNase L mutations in
the development of prostate cancer. This suggested to some that there
were perhaps other environmental or population differences that
affected the contribution of RNase L mutations to prostate cancer
susceptibility. Given that RNase L has a well established antiviral function,
Urisman, et al. hypothesized whether the observed differences in
susceptibility could be explained by the fact that mutations in RNase L
actually led to a greater susceptibility to a viral agent [45]. RNA derived
from biopsied prostate tumors with and with out mutations in RNase L was
hybridized to the ViroChip. A distinct gammaretrovirus was identified that
was detected in 8/20 (40%) tumors homozygous for the mutation in
RNASEL, while retroviral sequences were only detected in 1/66 (1.5%)
tumors bearing at least one wild-type allele. This virus appeared to be
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most closely related to xenotropic murine leukemia virus lending itself to
the name Xenotropic Murine-like Retrovirus (XMRV) and represented the
first of its kind to be detected in humans. In situ hybridization of prostatic
tumors with XMRV derived probes and immunohistochemistry probing for
viral retroviral proteins showed the presence of the virus in the tumors
suggesting there could be a link between XMRV infection and prostate
cancer. Later work has shown that XMRV is integrated in some tumor cells
and that replication of the virus is susceptible to RNase L [50]. It is currently
unclear whether XMRV plays a causal role in prostate cancer or whether
its presence is a secondary event.

Identification of HTCV-UC1. In an effort to identify novel respiratory
pathogens, respiratory secretions collected from patients with influenzalike symptoms were screened by conventional assays for respiratory
syncytial virus, influenza virus, parainfluenza virus, adenovirus, and
picornaviruses (rhinoviruses and enteroviruses). Samples that remained
negative after all diagnostic testing were then analyzed with the ViroChip.
One array had a hybridization pattern suggesting that a cardiovirus was
present in the sample [20]. Conventional diagnostic testing panels for
respiratory viruses do not include any members of the Cardiovirus genus in
the family Picornaviridae.

Primers were designed from the highest

intensity oligonucleotides and from alignments of conserved regions of
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the known cardiovirus genomes in order to try and amplify portions of the
cardiovirus present in the sample. The full sequence of this cardiovirus,
HTCV-UC1, was then obtained. Testing of 428 respiratory specimens failed
to identify additional cases. However, similar viruses were identified in 6
out of 767 stool samples tested [20]. HTCV-UC1 appeared to be closely
related to Saffold-like cardioviruses, which were initially discovered using
the DNase-SISPA strategy [19,21,22]. These studies define a new group of
cardioviruses which seemed to be the first human cardioviruses and have
tropism for both the respiratory and gastrointestinal tract. The role of these
viruses in human disease remains to be determined.

Identification of animal viruses. Two final examples demonstrate the
universality of pan-viral microarrays designed using all available viral
sequences. By including sequences from all viruses without restrictions
based on either viral taxonomy or putative host species, not only human
samples but plant and animal specimens can be analyzed.

In one

instance, the ViroChip was used to analyze liver tissue from a beluga
whale that had died mysteriously in an animal park.

A strong

hybridization signature from conserved coronavirus probes was observed
on the ViroChip, which ultimately led to the identification and complete
sequence of a highly divergent, novel coronavirus [51].
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The ViroChip was also used in the discovery of an avian bornavirus
found in samples derived from cases of a disease called proventricular
dilation disease (PDD) [52]. PDD is an inflammatory disease affecting over
50 species of parrots as well as other orders of birds. It had been long
thought that there was an infectious etiology for this disease and a
number of viral agents had been implicated over the years. For example,
electron microscopy analysis led some to believe that a paramyxovirus
was responsible, but this was later ruled out [52]. Other reports came out
reporting the culturing of an unidentified virus, but this virus was never
identified [52]. ViroChip analysis of PDD cases versus controls suggested
that a novel bornavirus, referred to as avian bornavirus (ABV), was present
in 62.5% of the PDD samples and none of the controls (0/8). Mass
sequencing (described in the next section) was used to obtain the full
bornavirus genome from one of the samples. Further PCR screening of
additional PDD samples revealed that the avian bornavirus was detected
in 71% (5/7) of PDD cases and none (0/14) of the controls. Given the high
correlation of ABV with PDD samples and not controls, it is highly
suggestive that this virus could in fact be the etiologic agent of PDD. This
case perfectly highlights the limitations of conventional approaches since
for years the etiology of this disease was unknown and now the ViroChip
has identified what could potentially be the causative agent of PDD.
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Pan-viral microarrays have proven to be successful tools for the
detection of known viruses and the identification of multiple novel viruses.
In conjunction with sequence independent PCR, microarrays offer a
robust readout to define the nature of viruses present in a specimen.
However, one key limitation of pan-viral microarrays is that highly
divergent viruses that have little to no nucleotide similarity with known
viruses will not be detected since the technology depends on crosshybridization between the unknown virus and probes derived from known
viral genomes.

DNA sequencing methods
Dideoxy sequencing or Sanger sequencing, first described in 1977
[53], has been the dominant DNA sequencing technology used during the
last ~30 years. In the dideoxy sequencing process, primers designed to
bind to a template of interest are added with dideoxynucleotides to a
polymerase extension reaction.

Incorporation of a dideoxynucleotide

prevents further extension of the primer-driven DNA synthesis reaction. In
the

automated

form

of

Sanger

sequencing,

each

of

the

4

dideoxynucleotides is labeled with a distinct fluorescent dye. The
truncated synthesis products are then run through a capillary containing a
denaturing polymer that provides single base pair resolution separation.
As each product passes through the end of the capillary it is excited by
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light and the resulting fluorescence is recorded as one of four
wavelengths, each corresponding to a different base. In this way, the
sequence of the template can be deduced by determining which
dideoxynucleotide

was

incorporated

at

each

position

of

the

complementary sequence. The typical sequence read length can reach
750-800 bp. This technology has been the cornerstone of all significant
sequencing projects up to 2005, including the sequencing of the human
genome.

Efficiencies gained in the monumental effort to sequence the

human genome have

enabled the

production

costs

of Sanger

sequencing in large genome sequencing centers to fall to as little as $0.35
per read (as of this writing).
Starting in 2005, multiple new sequencing technology platforms
(“NextGen”) emerged that have far surpassed conventional Sanger
sequencing in terms of increased total sequence production capacity
and decreased cost.

While there are many NextGen platforms, in this

review, we will limit our discussion to those that have been effectively
utilized to date in the efforts to identify novel viruses.

These include 454

pyrosequencing [54], commercially available in the form of the Roche FLX
instrument and Solexa technology, which is marketed as the Illumina
Genome Analyzer.
454 pyrosequencing technology differs from Sanger sequencing in
that natural nucleotides are used in the sequencing reaction.
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Rather

than monitor the incorporation of nucleotides directly, successful
incorporation of a nucleotide is inferred by measuring the quantity of
inorganic phosphate (PPi) produced. PPi is stoichiometrically converted
to ATP, which provides energy for luciferase. The quantity of light that is
produced by luciferase as a given nucleotide is added to the reaction is
indicative of the number of bases incorporated at that step.

By

repeatedly adding dATP, dCTP, dGTP and dTTP into the reaction in series,
up to 250 bp of contiguous sequence can be determined.

Another key

feature of the 454 technology is that hundreds of thousands of these
sequencing reactions are carried out simultaneously on independent
beads.

This is accomplished by generating 1:1 DNA template:bead

complexes. First the target DNA to be sequenced is randomly sheared
into fragments and then ligated to adapters. Single stranded template
DNA is isolated, mixed with the beads and then subject to emulsion PCR
to clonally amplify the template on each bead.

Next, the beads are

distributed into a fiber optically constructed plate (PicoTiterPlate) that
contains millions of tiny wells. Within each well that receives an individual
bead, an isolated environment is created for the sequencing of each
template, resulting in parallel sequencing of hundreds of thousand of
templates at once. Currently, one 454 sequencing run produces ~400,000
sequence reads of an average read length of ~250bp with imminent
expansion of its capacity to ~1,000,000 reads of ~ 400 bp [55].
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Solexa sequencing also uses a synthesis approach, but differs from
454 pyrosequencing in a number of ways. Unlike the bead format of the
454 platform, templates to be sequenced via Solexa sequencing are
affixed to a solid surface. Adapter sequences are ligated onto the
templates just as with 454, however, in Solexa sequencing these adapters
not only serve as priming sites for PCR and sequencing, but they are also
critical for the affixation of complementary templates to the solid surface
through

a

mechanism

called

bridge

amplification.

The

bridge

amplification generates clusters of amplified template on the solid surface,
where each cluster represents a different template. Solexa uses a unique
chemistry that incorporates fluorescently labeled reversible terminator
nucleotides in the sequencing reaction. The nucleotides are fluorescently
labeled with different colors so that all four can be added to the reactions
simultaneously. Due to the termination property of the nucleotides, only
one individual nucleotide can be incorporated into each sequence
during one sequencing cycle. The color of the fluorescent label
incorporated into the sequences of each cluster is recorded and discerns
which nucleotide was incorporated. Removal of the terminator group on
the

nucleotide

just

added

enables

incorporation

of

the

next

complementary nucleotides and the cycle is repeated. The length of the
read is dependent on the efficiency of removing the chain terminator
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group at each step.

Currently, Solexa sequencing generates ~40-50

million sequences of a read length of ~35bp [55].
To date, all three of these technologies, Sanger sequencing, 454
sequencing and Solexa sequencing, have been used to characterize
novel viruses. A schematic for generalized strategies of virus detection
using mass sequencing are outlined in Figure 1.2.

Sequence-independent amplification and sequencing strategies for virus
detection
Meyerson and colleagues conducted the first proof of principle
experiment to demonstrate that extensive sequencing of nucleic acids in
a specimen in conjunction with computational subtraction could be used
to detect pathogens [56]. They examined a tissue specimen from a case
of post-transplant lymphoproliferative disorder (PTLD), knowing that most
cases of PTLD are caused by Epstein Barr virus (EBV). A cDNA library with
27,840 sequences was generated and each individual sequence was
compared to the human genome in order to identify those sequences of
human origin.

These sequences were then eliminated from further

consideration in a process termed “transcript filtering”.

The remaining

sequences that did not match human genomic sequences were
postulated to be derived from microbial organisms present in the sample.
In fact, from this library, 10 sequences that did not match any human
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Figure 1.2: Schematic of mass sequencing strategies for detection of known and novel
viruses
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sequences but had similarity to EBV were identified. Furthermore, these
sequences could only be amplified from EBV infected tissues and not from
controls, thus showing the potential power of mass sequencing strategies.

Identification of human bocavirus. The discovery of human
bocavirus (HBoV) marked the 1st example of discovery of a novel virus by
direct high throughput sequencing of clinical specimens (Figure 1.1B) [57].
In this study, pools of respiratory samples were ultracentrifuged, filtered,
and DNase treated to produce samples for analysis that were highly
enriched for intact viral particles (in which the genome is protected from
DNase treatment) and to minimize the amount of other contaminating
DNAs. In contrast to the discovery of human metapneumovirus, in which
primers were arbitrarily chosen for amplification, a random PCR
amplification strategy was used for amplification in the HBoV study. The
amplified products were then cloned and ~300-500 clones were
sequenced without any effort to identify specific amplicons.

In this

analysis, 20% of the sequences showed similarity to viral sequences, the
majority of which were derived from known viruses. However, some of the
sequences had only limited similarity to viruses in the Parvovirdae family,
and more specifically the genus Bocavirus. The respiratory samples that
were initially pooled together for sequencing analysis were independently
screened by PCR for the presence of the novel bocavirus of which two
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tested positive. Further PCR screening of other pediatric respiratory
specimens revealed that HBoV could be detected in 3.1% of the samples.
The potential role of human bocavirus in respiratory disease and
gastroenteritis has been investigated in numerous subsequent studies.
These epidemiologic and seroepidemiologic analyses have determined
incidence rates of bocavirus between 2.7-19% (in respiratory secretions)
and seroprevalence rates of 94.7-98.3% in healthy adults [14]. As with
human metapneumovirus, this high seroprevalence rate suggests that
HBoV may be well established in humans and could be an important
human pathogen.

Identification of novel polyomaviruses. For 36 years following the
culture based discovery of JC virus (JCV) and BK virus (BKV) in 1971, it was
assumed that these were the only two human polyomaviruses.

That

picture changed dramatically in a 12 month span in 2007-2008 as 3 novel
human polyomaviruses were discovered, all by use of high throughput
sequencing strategies.

In 2007, sequencing of randomly amplified

products generated from clinical respiratory samples resulted in the
detection of 2 novel polyomaviruses, KI polyomavirus (KIV) and WU
polyomavirus (WUV) [58,59].

KIV was identified using the same

experimental strategy that led to the discovery of human bocavirus [57].
The discovery of WUV followed a parallel approach with the exception
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that individual respiratory specimens rather than pooled specimens were
analyzed. In both cases, sequences were identified with limited similarity
(≤50%) at the amino acid level to the known primate polyomaviruses at
the time.
The full genomes of KIV and WUV were sequenced and analyzed.
Phylogenetic analysis demonstrated that KIV and WUV were actually most
similar to each other (~65-70% amino acid identity) and appeared to
represent a new subclass of polyomaviruses. Both of these viruses shared
many similarities that distinguish them from JCV and BKV, including the
lack of an Agno protein, the absence of a C-terminal extension domain of
the Large T antigen, and altered origins of replication. In terms of tropism,
neither WUV nor KIV have been detected to date in urine, in contrast to
JCV and BKV which are both frequently detected in urine. Both WUV and
KIV have been found to be prevalent in the respiratory tract, with WUV
having a prevalence of up to 7% in respiratory infections with KIV’s
prevalence generally slightly lower [60-65]. They are often found as part of
a co-infection with other viruses and have also been found in respiratory
secretions of asymptomatic individuals, so the pathogenesis of these
viruses is presently unclear. Persistence of WUV in respiratory secretions of
immunocompromised individuals has been described [66].
A third novel polyomavirus was discovered in 2008 in human merkel
cell carcinomas (MCC) [67]. Merkel cell carcinoma is an aggressive form
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of skin cancer that has a 33% mortality rate which has been increasing in
incidence in recent years [68].

The rationale for pursuing a potential

infectious etiology for MCC lies in the increased susceptibility among
immunosuppressed patients [69]. Feng et al. generated cDNA libraries
from four MCC tumors and subjected them to high-throughput mass
sequencing

using

454

pyrosequencing.

~400,000

sequences

were

generated. Poor quality sequences and those that aligned to known
human RNA, human chromosomes, mitochondria, or immunoglobulin
sequences were removed from the final analysis. Of the remaining 2,395
sequences, one sequence was detected which had limited similarity to a
primate polyomavirus. The full genome of the polyomavirus represented
by this sequence, referred to as Merkel cell polyomavirus (MCV), was
subsequently sequenced.

Phylogenetic analysis determined that MCV

was most closely related to African green monkey polyomaviruses and
was only much more distantly related to JCV, BKV, WUV and KIV. Upon
screening 10 other MCC tumors by PCR and Southern blotting, it was
found that 80% of them were positive for MCV, whereas only 5/59 control
tissues were positive. The virus was also found in 4/25 (16%) skin and nonMCC skin tumors. A striking observation was that the MCV DNA was
clonally integrated into the MCC tumors, indicating that MCV integration
is an early event during the transformation process and thus may
contribute

to

tumorigenesis.

Mechanistically,
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this

may

be

the

consequence of the putative transforming ability of the MCV T-antigen or
alternately it may be due to cellular alterations resulting from integration
of the MCV genome, or a combination of the two. Follow up studies have
generally corroborated the detection of MCV in the majority of Merkel
tumor specimens [70-73]. If future studies definitively implicate MCV in the
etiology of Merkel cell carcinoma, it would be the first clear cut example
of a polyomavirus playing a role in human cancer, after many years of
debate over the role of polyomaviruses in human cancer [74].

The

discovery of Merkel polyomavirus was the first published report using 454
sequencing to discovery a novel virus. Of relevance for the continuing
quest to identify potential infectious etiologies of human cancers, the fact
that only 1 out of 400,000 sequence reads yielded a viral sequence
suggests that as sequencing technologies continue to improve, it will be
possible to detect viral nucleic acid sequences present at even lower
abundances.
The identification of 3 novel polyomaviruses within a 12 month span
by use of similar high throughput sequencing strategies underscores both
the promise of such strategies as well as the fact that the diversity of
viruses that constitute the human virome is vastly underestimated.
Moreover, the identification of a novel human polyomavirus that appears
to be strongly associated with a human tumor greatly broadens our
paradigms of polyomaviruses.

As the application of mass sequencing
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strategies gain favor, we anticipate that most viral families will gain new
members that may similarly broaden our understanding of those virus
families.

Even more tantalizing is the possibility that completely novel

families of viruses may be identified through the use of such approaches.

Detection of an arenavirus in a fatal transplant cluster. Another
example of the utility of 454 pyrosequencing in detecting viruses comes
from identification of an arenavirus associated with a cluster of fatal
transplant-associated diseases [75]. Cerebrospinal fluid, serum, and tissue
samples from two individuals who died 4-6 weeks after receiving organ
transplants from the same donor were sequenced. 14 fragments out of
94,043 sequence reads had sequence similarity to LCMV. The results of
this analysis suggested the specimens contained an arenavirus, which was
then isolated in tissue culture from an infected kidney homogenate.
Serum antibodies of both individuals reacted with the viral culture and
were used to show immunostaining of viral antigens in the tissue
specimens. While significant debate over whether this virus is indeed novel
is ongoing [76], this case nonetheless illustrates two important points: (1)
high throughput sequencing is a robust methodology for detection of
viruses both known and novel; (2) as strictly sequence based methods
gain

prominence,

viral

taxonomy

needs

accommodate sequence based classification.
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to

be

restructured

to

Avian bornavirus sequencing. The initial discovery of a novel avian
bornavirus (as discussed previously)

was based upon hybridization of

specimens to a pan-viral microarray [52].

In order to sequence the

complete genome of the avian bornavirus, Kistler et al. utilized Solexa
sequencing technology. A total of 1.4 million 33 bp reads were obtained
from specimens positive for the virus. The sequences were filtered for read
quality, sequence complexity, and the presence of inserts which reduced
the number of usable reads to 600,000. Host sequences, approximately
50% of all the reads, were computationally subtracted from this pool by
comparison to sequences of all available avian species. Comparison of
the remaining sequence reads to all Borna Disease virus sequences
identified 1,400 sequences that appeared to be derived from this novel
virus. Conventional PCR-based methods were required to fill in the gaps
of the genome where no sequences were identified in the mass
sequencing. Retrospective analysis once the full genome of the avian
bornavirus was obtained showed that there were twice as many
sequences derived from the virus than initially identified. In total,
sequences from the virus constituted 1% of all the sequence reads.

This

study was the first to use Solexa technology for de novo sequencing of a
novel virus genome.
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Identification of seal picornavirus. As demonstrated with some of
the other methods, mass sequencing is not limited to the analysis of
human samples. Application of mass sequencing to the supernatant of
cells inoculated with a nasal swab from a seal yielded sequences that
had 22-41% amino acid identity to known picornaviruses [77]. The degree
of divergence of this virus, called seal picornavirus 1 (SePV-1), to other
picornaviruses suggests that this virus might represent a new genus in the
family Picornaviridae. Moreover, this is the first example of a picornavirus
infecting a marine mammal, which again underscores our relative
ignorance regarding the diversity of viruses that surround us.

Mass sequencing of human stool. Recently, high throughput
sequencing has been applied to the analysis of human stool samples
collected from healthy individuals [78,79]. Sequences from phage and
plant viruses were dominant in the analysis of healthy stools. However, the
question: “What is viral content of diarrheal stools?” remained a major
question. Specifically, I wanted to know what viruses could be found in
diarrheal stools, if I could find novel viruses, and if I found novel viruses,
might they be linked to diarrhea or some other human disease?

It

therefore became my interest to apply cutting edge technologies like
mass sequencing to examine which viruses are present in diarrhea
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specimens and to search for novel viruses potentially associated with
diarrhea.

Impact of diarrheal disease
Diarrhea is estimated to be the third leading cause of death due to an
infectious disease [80]. While data from socioeconomically developing
countries is sparse, mathematical modeling based on the data that is
available suggests that ~2 - 2.5 million children under the age of 5 die
every year from diarrhea. The overall disease burden is much greater with
an estimated 1.4 billion episodes of diarrhea occurring each year in
developing

countries

and

9

million

of

these

episodes

requiring

hospitalization [81]. In developing countries, conditions such as poor
sanitation, malnutrition, poor healthcare, and the rising rates of HIV
infections in many regions all contribute to the burden of diarrheal disease
[81,82]. In developed countries, mortality rates have been drastically
reduced by the use of oral rehydration therapy as a treatment for
diarrhea. Despite this, there are still an estimated 211-375 million episodes
of acute diarrhea that occur each year in the United States, with 1.8
million episodes resulting in hospital admissions [83].
There are over 20 known enteropathogens which include bacteria,
viruses and parasites. A small percentage of the annual cases of diarrhea
are attributable to parasite infections with most occurring in developing
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countries. Viruses are responsible for causing the greatest number of the
annual cases of diarrhea, while bacteria are responsible for a significant
portion of the cases, but still less than those caused by viruses [84-86].
Rotaviruses, astroviruses, caliciviruses, and adenoviruses are the major
causes of viral diarrhea [87,88]. These viruses were all identified as
etiologic agents of diarrhea in the 1970s [89-92]. While there are other
viruses that have been suggested to be linked to diarrhea, there have
been no major discoveries of new enteric viruses since the initial
identification of the four major viral diarrhea pathogens [87,88]. This
becomes important in light of the fact that ~20-40% of cases of acute
sporadic diarrhea are caused by unknown etiology [93]. Likewise, it is
estimated that up to ~12-40% of gastroenteritis outbreaks are also of
unknown etiology even after extensive testing, suggesting that there is a
diagnostic gap [94,95]. In the United States alone, it is estimated that there
are 5,000 yearly deaths which occur as a result of gastroenteritis of
unknown etiology (GUE), accounting for 77% of the deaths in U.S. caused
by diarrhea [96]. Given that viruses play such a large role in the disease
burden of diarrhea, that no new viral cause of diarrhea has been
discovered in the last 30 years, and given that a number of viruses have
been described morphologically upon observation of their presence in
loose stools but not characterized further, there is good reason to believe
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that there are other viral agents of diarrhea that have yet to be
discovered [97-99].
Mass sequencing of pediatric diarrhea samples which were
determined to be negative for known enteric agents by conventional
assays such as PCR and enzyme immunoassays was carried and is
described in Chapter 2. Use of this methodology in screening of acute
sporadic diarrhea samples resulted in the identification of a novel
astrovirus which will be referred to as Astrovirus MLB1 (AstV-MLB1), and
which is described in Chapters 2-4. In addition, the use of mass
sequencing to analyze diarrhea samples from a gastroenteritis outbreak
resulted in the identification of an additional novel astrovirus referred to as
Astrovirus VA1 (AstV-VA1), which is described in Chapter 5.
Astroviruses were first described in 1975 by electron microscopic
examination of fecal extracts [100,101]. Since this first discovery,
astroviruses infecting cattle, sheep, cats, dogs, deer, chickens, turkeys,
ducks, and bats have also been described in addition to the eight human
serotypes that have been identified [102,103]. The human astroviruses
most frequently cause diarrhea in children under the age of 2, the elderly,
and immunocompromised individuals [104]. Typical symptoms are watery
diarrhea, while vomiting, headache, fever, abdominal pains, and
anorexia occurring to a lesser extent. Symptoms usually last 2-4 days.
Astroviruses account for 10% of sporadic cases of non-bacterial diarrhea
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and the magnitude of their impact on disease burden seems to be
increasing with the development of more sensitive technologies for
astrovirus detection and increased surveillance [105].
The name astrovirus comes from the observation that ~10% of the 28
nm particles have a star like morphology. Astroviruses are non-enveloped,
single stranded, positive sense RNA viruses. The genomes, which range
from 6.4 kb to 7.9 kb in length, are polyadenylated, contain 3 open
reading frames (ORFs 1a, 1b, and 2), and have both 5’ and 3’
untranslated regions (Figure 1.3). Their genomic organization, which is
similar to that of caliciviruses, is: (from 5’ to 3’) ORF 1a, which encodes a
serine protease; ORF1b, which encodes the RNA dependent polymerase;
and ORF 2, which encodes the structural proteins. A frameshift must occur
during the translation of ORF 1a in order for ORF 1b to be translated. ORF 2,
on the other hand, is translated from a sub-genomic RNA and produces a
polyprotein which is cleaved by cellular proteases [106].

Serine Protease

5’

ORF 1a

Structural Proteins

ORF 2

2.8 kb

ORF 1b

2.4 kb

An3’

1.6 kb

RNA Polymerase

Figure 1.3: Schematic of genomic organization of astroviruses. Sizes of the open reading
frames correspond to those of Human Astrovirus 1.
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This dissertation manuscript describes work that was done to first
identify which viruses can be found in diarrhea samples and which then
led to the discovery of multiple novel astroviruses (AstV-MLB1 and AstVVA1). The remaining body of this manuscript describes the efforts to further
characterize these newly discovered astroviruses and to begin answering
important questions raised by their discoveries. Characterization of these
viruses may reveal that astroviruses contribute more to the global disease
burden of gastroenteritis than previously recognized. Furthermore, the
discovery of two novel astroviruses in such a short time frame indicates
that there may be more astroviruses waiting to be discovered and that
perhaps more energy should be devoted to studying astroviruses since
the work described herein only begins to scratch the surface in terms of
our understanding of astrovirus biology.
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ABSTRACT
Worldwide, approximately 1.8 million children die from diarrhea annually,
and millions more suffer multiple episodes of nonfatal diarrhea.

On

average, in up to 40% of cases, no etiologic agent can be identified. The
advent of metagenomic sequencing has enabled systematic and
unbiased characterization of microbial populations; thus, metagenomic
approaches have the potential to define the spectrum of viruses,
including novel viruses, present in stool during episodes of acute diarrhea.
The detection of novel or unexpected viruses would then enable
investigations to assess whether these agents play a causal role in human
diarrhea. In this study, we characterized the eukaryotic viral communities
present in diarrhea specimens from 12 children by employing a strategy of
‘micro-mass sequencing’ that entails minimal starting sample quantity
(<100 mg stool), minimal sample purification and limited sequencing (384
reads per sample). Using this methodology we detected known enteric
viruses as well as multiple sequences from putatively novel viruses with only
limited sequence similarity to viruses in Genbank.

INTRODUCTION
While

traditional

sequencing

approaches

are

designed

to

characterize genomes of a single species of interest, metagenomic
- - 42 - -

approaches, such as mass sequencing, transcend species boundaries
allowing one to explore the makeup of microbial communities. Such
methods provide a holistic look at microbial diversity within a given
sample, completely bypassing the need for culturing [107-111]. Previous
efforts in this field have explored the structure of virus communities in
ecosystems as diverse as the ocean [107,112] and the human gut [78,79].
To date, the reported metagenomic studies of human stool have been
limited to analysis of 4 specimens collected from 3 healthy patients [78,79].
To our knowledge, no metagenomic investigation of the viral diversity
found in human diarrhea has previously been described. Human diarrhea
is the third leading cause of infectious deaths worldwide and is responsible
for ~ 1.8 million deaths in children under age five each year [80]. Bacteria,
protozoa and viruses have all been implicated as causal agents. Chief
among

the

known

etiologic

agents

astroviruses, and adenoviruses [113]

are

rotaviruses,

noroviruses,

However, it is estimated that on

average up to 40% of diarrhea cases are of unknown etiology, suggesting
that unrecognized infectious agents, including viruses, remain to be
discovered [85,93,114-116]. Mass sequencing affords an opportunity to
explore the viral diversity (including both known and novel viruses) present
in stool during acute episodes of diarrhea in a systematic and unbiased
fashion, thereby laying the foundation for future studies aimed at
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assessing whether any novel or unexpected viruses detected play a
causal role in human diarrhea.
In this study, mass sequencing was applied to explore specifically
the viral communities present in pediatric patients suffering from diarrhea.
We anticipated that the viral communities would vary significantly from
specimen to specimen and that it would be desirable to sample broadly
from multiple patients to obtain an overall perspective on the diversity of
viruses that might be present.
experimental

strategy

was

Toward this end, a simple yet robust

developed

that

circumvented

certain

technical and economic limitations of conventional mass sequencing. In
both previous viral metagenomic studies of the human gut, large
quantities of fecal matter (~500g) were collected from adults and then
extensively purified to enrich for viral particles [78,79].

In contrast,

pediatric samples provide considerably smaller volumes of stool; therefore,
our strategy was designed to minimize the number of physical purification
steps so that as little as 30 mg of archived fecal matter could be analyzed.
Here we present data generated by performing what we refer to as
‘micro-mass sequencing’ of several hundred sequence reads per sample
from 12 different patients with acute diarrhea.

This analysis provides

evidence for the detection of known enteric viruses, viral co-infections,
and novel viruses.
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RESULTS
Aggregate library analysis. Metagenomic analysis was carried out
on fecal samples collected from 12 distinct pediatric patients suffering
from acute diarrhea. Patient characteristics are shown in Table 2.1. A
sequence independent PCR strategy was employed to amplify the
extracted nucleic acids from each sample [41]. 384 clones were
sequenced for each sample library. Because the goal of this project was
to define the diversity of viruses present in the clinical specimens
regardless of their relative abundance, nearly identical sequence reads
were clustered to generate a set of non-redundant sequence reads.
Unique, high quality sequence reads were then classified into broad
taxonomic groups based on the taxonomy of the most frequent top
scoring BLAST matches for each sequence. A total of 4,608 sequences
were generated, of which 3,169 passed through a quality filter and 2,013
of those contained unique sequence information. Of the unique
sequences passing through the filter, 1,457 (72%) could be identified by
similarity to sequences in the Genbank nr database based on tBLASTx (Evalue ≤10-5) alignments. The remaining 556 (28%) sequences had no
significant similarity to any sequences in the nr database and were
therefore categorized as being of ‘unknown’ origin. The 1,457 identifiable
sequences were further classified into categories based on their proposed
origin (Figure 2.1). 519 (35.6%) were most similar to eukaryotic viruses, 25
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Table 2.1: Sample Information.

Sample
D01
D02
D03
D04
D05
D06
D07
D08
D09
D10
D11
D12

Year
Collected
2005
1998
1984
1984
1980
2003
1999
1999
1981
1983
1978
2005

Age of Patient
14 mo
10 mo
NA
4 mo
NA
11 mo
23 mo
35 mo
NA
20 mo
NA
8 mo

# of high quality
sequence reads
365
348
302
311
243
153
352
302
302
195
253
198

#
of
unique
reads
166
104
281
154
168
132
186
167
294
146
103
129

Average
unique read
length (bp)
526
499
506
626
563
393
617
255
491
447
367
300

(1.7%) to phage, 857 (58.8%) to bacteria, 3 (0.2%) to fungi, and 20 (1.4%)
to human sequences.

The remaining 33 (2.3%) were most similar to

sequences that did not fall into the other previous categories and were
consequently labeled as ‘other’. For example, some of the sequences
had significant hits to mouse, fish, and plant genomes.
Individual library statistics. 384 clones were sequenced for each
individual sample. The proportion of high quality sequences for each
sample varied between 40% and 95% of the total clones (Table 2.1). The
percentages of unique sequences per sample ranged from 41% to 97% of
the high quality reads (Table 2.1). The average length of the unique, high
quality sequences ranged from 255 to 626 bp. Viral sequences constituted
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Figure 2.1: Composite analysis of all
sequences
Sequences from all 12 libraries were
categorized based on the best
tBLASTX scores (E-value: <10-5) as
viral, phage, bacterial, human,
fungal,
other,
or
unassigned.
Numbers in parenthesis represent
the number of sequences in each
category.

between 0-100% of the reads in each library (Figure 2.2). Some libraries
(e.g., D01 and D05) were predominantly composed of viral sequences
(64% and 95% respectively), whereas others consisted largely of bacterial
(e.g., D08 and D12) or unassigned (e.g., D03 and D07) sequences. Based
on the initial BLAST classification criteria, sequences with similarity to viruses
from 7 different viral families and three unclassified genera (picobirnavirus,
anellovirus and mimivirus) were detected in the 12 different samples (Fig.
2.2).

Five of the samples (D03, D05, D06, D08, and D12) contained

sequences from at least two different virus families known to infect
humans.
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Figure 2.2: Categorization of sequence reads based on best tBLASTX scores
(E-value: <10-5)
Pies on the left side of each box depict the categorization of sequences from individual
samples by phylotype: viral (V); phage (P); bacterial (B); human (H); fungal (F); other (O);
and unassigned (U). Pies on the right side of each box depict further characterization of
viral sequences by viral families/taxa: Reoviridae (Reo); Caliciviridae (Calici); Astroviridae
(Astro); anellovirus (Anello); picobirnavirus (Picobirna); Picornaviridae (Picorna); mimivirus
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(Mimi); Nodaviridae (Noda); Adenoviridae (Adeno); Parvoviridae (Parvo). Numbers in
parentheses indicate the number of sequence reads in each category.

Detection of known viruses.

The first specimen analyzed was a

positive control stool specimen that had tested positive for rotavirus (D01)
by enzyme immunoassay. It was our expectation that this sample would
yield sequences derived from the infecting rotavirus. In this library, 107
non-redundant sequence reads were identified as viral in origin, almost all
of which possessed ≥ 90% amino acid (aa) BLAST identity to known
rotavirus sequences in Genbank. The sequence data included cloned
fragments from all 11 RNA segments of the rotavirus genome.
An additional 11 stool specimens were then selected that had
tested negative in conventional PCR and enzyme immunoassays for the
known

diarrhea

viruses

(rotaviruses,

caliciviruses,

astroviruses,

and

adenoviruses). Despite such screening, sequences derived from the
canonical enteric viruses were detected in a number of samples.

For

example, calicivirus sequences were detected in D02 and D06, astrovirus
sequences in D04, and adenoviruses were detected in D05 and D12.
Almost all individual sequence reads in these cases possessed >90% aa
identity to existing viral sequences in Genbank.
Adeno-associated virus (AAV), a member of the Parvoviridae family,
was detected in two samples, D11 and D12. These viruses are known to
infect the gastrointestinal tract, but are not thought to be enteric
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pathogens. For productive infections or reactivation from a latent state,
AAV requires co-infection with a helper virus that is most commonly an
adenovirus or less typically, a herpesvirus [117]. In D12, adenovirus
sequences were detected. No additional viruses were detected in D11.
Detection of novel virus sequences.

In many of the libraries,

individual sequence reads were detected that possessed ≤ 90% aa
identity to their highest scoring BLAST hit (representative sequences are
listed in Table 2.2) suggesting that these sequences might be derived from
novel viruses.

In part because BLAST alignments are based on local

sequence comparisons, BLAST is not an optimal method for making
taxonomic assignments. In order to more accurately and precisely assess
the relationship of these sequences to known viruses, we generated
phylogenetic trees using the maximum parsimony method [118]. In cases
where more than one sequence read hit the same region of a genome,
only one representative sequence read is listed in Table 2.2 and
phylogenetic trees are shown for only these representative sequences (Fig.
2.3, 2.4 and Fig. 2.S1-S4). Phylogenetic analysis revealed that many of the
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Table 2.2: Selected sequence reads with limited BLAST identity to known viruses
Sequence
Read
Accession
Top Hit
Sample #
Identity to top hit (Accession #)
Virus Family/Taxa
Human
picobirnavirus
D03
ET065742
78%
Picobirnavirus
strain
1-CHN-97
(AF246939)
Human
D03
ET065743
90%
coxsackievirus A19 Picornaviridae
(AF499641)
Human enterovirus
D06
ET067042
74%
Picornaviridae
91 (AY697476)
TTV-like mini virus
D06
ET067045
66%
Anellovirus
(AB026931)
Snow
Mountain
D06
ET067040
79%
Caliciviridae
virus (AY134748.1)
Norovirus
C14
D06
ET067041
88%
Caliciviridae
(AY845056.1)
Human astrovirus 4
D08
ET065575
57%
Astroviridae
(AY720891)
Human astrovirus 5
D08
ET065582
67%
Astroviridae
(DQ028633)
D08
ET065578
45%
TT virus (AB041963)
Anellovirus
Epinephelus
septemfasciatus
Nodaviridae
D09
ET066010
35%
nervous
necrosis
virus (AM085331)
Human
D10
ET066456
81%
picobirnavirus
2- Picobirnavirus
GA-91 (AF245701)

sequences were divergent from known sequences on the order that
approximated a distinct subtype or genotype (Figures 2.S1-S4).

This

included two libraries with picobirnaviruses (D03, D10) (Figures 2.S1), two
with picornaviruses (D03, D06) (Figures 2.S2), two with anelloviruses (D06,
D08) (Figure 2.S3), and one with a norovirus (D06) (Fig. 2.S4).
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Figure 2.3: Phylogenetic analysis of highly divergent astrovirus-like sequence reads.
Maximum parsimony phylogenetic trees were generated by comparing the translated
amino acid sequence of individual sequence reads to the corresponding sequences
from known astroviruses. 1,000 replicates were generated with bootstrap values over 700
shown. A) Representative sequence read mapping to astrovirus serine protease ORF
(Accession number ET065575); B) Representative sequence read mapping to astrovirus
RNA polymerase (Accession number ET065582).

In several instances, much more highly divergent sequences were
detected that suggested that novel virus species might be present.

The

library generated for sample D08 included 7 unique sequence reads
derived from two loci that displayed 52-67% aa identity to human
astroviruses. Phylogenetic analysis of the individual sequence reads
suggested that a novel astrovirus was present in D08 (Figure 2.3). These
sequence reads were assembled into two contigs, one of ~800 bp that
mapped to ORF1a and one of ~500 bp that mapped to ORF1b. RT-PCR
and subsequent sequencing of the amplicon confirmed the presence of
the contigs in the original RNA extract as well as the contig assemblies
(data not shown). Phylogenetic analysis of the two contigs yielded trees
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essentially identical to those generated from the individual sequence
reads (data not shown).
In sample D09, we detected one sequence read which exhibited
limited similarity to viruses in the family Nodaviridae (Table 2.2). RT-PCR of
this sample using primers designed from the sequence read confirmed the
presence of a 229 bp fragment in the original RNA extract (data not
shown). Phylogenetic analysis of the sequence of the RT-PCR product
demonstrated that the nodavirus in sample D09 was highly divergent from
other known nodaviruses (Figure 2.4).

Figure 2.4: Phylogenetic analysis of a highly divergent nodavirus-like sequence read.
Maximum parsimony phylogenetic trees were generated by comparing the translated
amino acid sequence of one sequence read (Accession number ET066010) to the
corresponding RNA polymerase sequences of nodaviruses. 1,000 replicates were
generated with bootstrap values over 700 shown.

Finally, one sample, D03, contained five sequence reads that,
based on the top tBLASTX hits, contained 47% to 52% aa identity to
endonuclease genes in the amoeba-infecting virus Acanthamoeba
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polyphaga mimivirus. These sequences also possessed approximately
similar levels of sequence identity to a number of bacterial genomes and
phage

genomes

containing

putative

endonuclease

proteins.

Phylogenetic analysis comparing the sequence reads to the top scoring
BLAST hits (Figure 2.S5) did not conclusively clarify the origin of these
sequences. Further experimentation will be required to unambiguously
determine if these sequences are derived from a mimi-like virus, phage, or
a bacterial species.
Unassigned sequences. Some sequences in the libraries had no
significant hits to any sequences in the Genbank nr database. Samples
D03 and D07 had a large abundance of these ‘unassigned’ reads.
Relaxing E-value thresholds for designating various sequence categories
resulted in the ability to classify a greater number of these unassigned
sequences; however, many of these classifications likely represent
artifactual alignments. Viral assignments remained largely unaffected,
even when E-value thresholds as permissive as 10 were applied.

DISCUSSION
We examined the diversity of viral communities in stools from 12
children with diarrhea using a strategy we describe as ‘micro-mass
sequencing’.

This strategy, which entails crude purification of fecal

suspensions, nucleic acid purification, random PCR amplification, and
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cloning and sequencing of several hundred colonies, effectively
detected known enteric viruses, viral co-infections, and novel viruses. In
most traditional metagenomic studies, large sample volumes are
subjected to multiple stages of filtration and purification before
sequencing. For example, in previous metagenomic studies of the gut,
500g of fecal samples were initially collected for the analyses. Because
clinical pediatric diarrhea specimens are much more limited in volume,
we chose to both minimally purify the samples and to employ a random
PCR amplification strategy. These combined steps enabled us to rapidly
generate sequencing libraries from small quantities of archived stools (30100 mg).

Furthermore, we wished to sample broadly from multiple

patients because of the large number of viruses known or suspected to be
associated with diarrhea. Therefore, rather than sequence few specimens
in great depth as has been done previously (10,000 sequences per
sample) [78], we focused on sequencing fewer clones (384 per sample)
from more samples (12 specimens).
Our analysis detected viruses, bacteria, host, phage and other
sequences (Figures 2.1 and 2.2). The presence of non-viral sequences in
the libraries was not surprising as only minimal efforts were made to enrich
for viral sequences. In fact, the goal of this strategy was to manipulate
the specimens as little as possible in the interest of simplicity. Even so, in a
few libraries, 100% of the sequence reads were of viral origin.
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Additional

processing, such as treating the specimens with DNase, reduced the
background signal and increased the percentage of viral reads in some
instances (data not shown).
Viral sequences were detected in all but one sample. Interestingly,
a number of DNA viruses (bacteriophages, adenoviruses, and adenoassociated viruses) were detected in our analysis, despite our use of a
methodology focused on purification of RNA. While it is possible that RNA
transcripts from these viruses were purified [119], it is more likely that viral
DNA was co-purified with RNA, as is common in other RNA purification
methods [120]. PCR analysis of samples D05 and D11 in the absence of
reverse transcription, yielded positive results for adenovirus and adenoassociated virus, respectively, indicating that viral DNA was present in the
RNA preparations (data not shown).
Analysis of this initial cohort of 12 specimens yielded a wealth of
original findings. In contrast to previous metagenomic studies of stool [78],
a number of known human viruses were detected in these clinical
specimens. These included common enteric pathogens such as rotavirus,
adenovirus, calicivirus, and astrovirus.

In addition, putatively benign

adeno-associated viruses (AAV) were also detected which are not
generally associated with human diarrhea. Aside from one sample known
to contain rotavirus, we intended to analyze the viral communities present
in samples that were not infected by known enteric pathogens in order to

- - 56 - -

identify viruses that might be responsible for the unexplained cases of
diarrhea. The fact that micro-mass sequencing detected these canonical
viruses in some of the specimens, despite conventional diagnostic testing
by EIA and PCR, underscores the sensitivity limits of conventional
diagnostics.
Detection of novel viruses. Sequences were detected in this study
from at least 9 putatively novel viruses.

For 7 of these sequences, the

degree of divergence observed based on phylogenetic analysis
suggested that they might represent novel virus subtypes or genotypes of
picobirnavirus, enterovirus, TT virus and norovirus (Figures 2.S1-S4).
Picobirnaviruses belong to an unclassified genus of double stranded RNA
viruses and have been detected in fecal matter from human and other
animals both with and without diarrhea [121]. Only a limited number of
picobirnavirus sequences have been previously described in the literature
and thus the identification of two novel picobirnaviruses significantly
expands the known diversity of this taxonomic group, underscoring the
unrecognized viral diversity inhabiting the human body.
Sequences representing a divergent norovirus were detected in
sample D06 (Figure 2.S4).

Phylogenetic analysis of individual sequence

reads that mapped to the RNA polymerase and the NS4 regions of human
norovirus suggested that these sequences were derived from a novel or
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unsequenced member of norovirus genogroup 2. In the initial screening
by conventional PCR, this sample tested negative for norovirus. Upon
closer examination, four mutations were observed in one of the PCR
primer binding sites, which plausibly hindered the PCR screening assay
[85].
In two samples, much more highly divergent sequences were
detected.

In D08, phylogenetic analysis of 7 unique sequence reads

strongly suggested that a novel astrovirus species was present (Figure 2.3).
The observed sequence variation between these sequence reads and
the known astrovirus genomes greatly exceeds the variation that exists
between the 8 known serotypes of human astrovirus, suggesting that this
virus is not simply another serotype of the known astroviruses. Astroviruses
are non-enveloped, single stranded, positive sense RNA viruses that
account for up to 10% of sporadic diarrhea cases [105]. Infections with
astroviruses most frequently cause watery diarrhea lasting 2-4 days, and,
less commonly vomiting, headache, fever, abdominal pain, and anorexia
in children under the age of 2, the elderly, and immunocompromised
individuals [104]. The detection of this genetically distinct astrovirus raises
the question as to whether or not this is an authentic human virus, and if so,
whether or not it is a causal agent of human diarrhea.
Another novel sequence detected appeared by phylogenetic
analysis to belong to the family Nodaviridae (Figure 2.4). Nodaviruses are
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small single-stranded, positive sense, bipartite RNA viruses, divided into
two

genera,

the

alphanodaviruses

(insect

viruses)

and

the

betanodaviruses (fish viruses). Currently, none of the established family
members are known to naturally infect mammals although experimental
manipulation of the viral genome has enabled viral replication in a wide
array of organisms including mammals [122].

While it is tempting to

speculate that this might represent the first instance of human infection
with a nodavirus, further experimentation such as serological analysis is
required

to

definitively

answer

this

question.

Another

plausible

explanation is that the virus may be present simply as a result of
consumption of fish infected by the virus. A prior report describing the
presence of plant virus RNAs in human stool has similarly been attributed
to dietary exposure [78]. Incidentally, some fish genomic sequences were
detected in this particular sequence library (D09 “other” bin) supporting
the possibility of dietary exposure. However, the potential piscine origin of
this virus would not necessarily preclude its role as an etiologic agent of
human disease.
The micro-mass sequencing approach, like any other experimental
methodology capable of detecting novel viruses (such as culture or
degenerate PCR), cannot of course by itself determine whether the newly
detected agent is pathogenic.

However, this strategy can generate

novel, testable hypotheses such as “Are these novel viruses involved in the
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etiology of human diarrhea?” and “What is the true host of these viruses?”
that could not be asked in the absence of the knowledge that these
viruses existed.
Unassigned reads. 556 out of the 2013 (28%) unique high quality
sequences were binned as unassigned by the BLAST criteria. Of these, 23
were identified as containing repetitive elements or low-complexity
sequence by RepeatMasker [123,124] thus explaining the lack of
meaningful BLAST alignments. The origin of the remaining 533 sequences
that were unassigned is uncertain, but they could be derived from
unannotated host genome, novel or unsequenced microbes, or dietary
sources which have not been sequenced. However, it is also possible that
some of these sequences could represent viruses that have no
appreciable similarity to sequences of currently known viruses. Extracting
more telling information from these sequences is a challenging problem
that will require the development of new computational measures
capable of detecting more distant evolutionary relationships than is
possible with existing methods. In addition, as more genome sequences
from diverse organisms and other genomic/metagenomic projects
become available, sequence similarity based methods may identify a
greater fraction of these currently unassigned sequences.
Diagnostic Applications and Implications. Our data suggest that
micro-mass sequencing might be of great diagnostic utility for a number
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of reasons. First, viruses escaping detection in conventional assays were
detected by micro-mass sequencing. In theory, the sensitivity of this
strategy is limited only by the depth of sequencing. As demonstrated here,
even shallow sequencing performed better than conventional diagnostics
in some instances.

In addition, the unbiased nature of the method

enabled detection of viruses not conventionally tested for. Moreover, coinfections were detected in multiple samples. Furthermore, for multisegmented viruses such as rotaviruses, reassortment of segments between
species is a major mechanism of viral evolution that can lead to the
emergence of more virulent strains [125]. Complete genome sequencing
of all segments simultaneously would yield completely unambiguous
identification of the viral genotype. In contrast to typical PCR or antibody
based assays that target a single segment or protein, micro mass
sequencing detected all 11 genomic RNA segments of rotavirus. In terms
of technical practicality, samples were only minimally manipulated
relative to traditional metagenomic sequencing [78,107,109,112], thereby
avoiding the time, labor, and use of specialized equipment required to
concentrate the specimens, rendering this methodology potentially
amenable to use in diagnostic laboratories. As sequencing costs diminish
and efficiencies improve, mass sequencing could become a powerful
diagnostic tool.
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In summary, we have shown that micro-mass sequencing can
define the diversity of viral communities found in fecal samples from
diarrhea patients. Both known viruses and novel viruses were detected by
sequencing only a few hundred colonies from each sample library. These
studies will serve as the springboard for further interrogations of the roles of
these diverse viruses in the gastrointestinal tract.

Finally, our detection of

multiple novel viruses in this initial, limited exploration of a dozen samples
suggests that broader sampling of patient specimens is likely to be highly
fruitful in terms of identification of additional novel viruses.

MATERIALS AND METHODS
Clinical Archived Stool Specimens.
Melbourne Cohort. Stool samples were collected from children under the
age of 5 who were admitted to the Royal Children’s Hospital, Melbourne,
Victoria, Australia with acute diarrhea between 1978 and 1999.

Seattle Cohort. Stool samples were collected between 2003-2005 at the
Emergency Department of the Children’s Hospital and Regional Medical
Center in Seattle, Washington, USA as part of a prospective study
attempting to discern the cause of unexplained pediatric diarrhea.
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Diagnostic testing of stool specimens for known microbial diarrheagenic
agents.
Melbourne

Cohort.

Specimens

were

tested

by

routine

enzyme

immunoassays (EIA) and culture assays for rotaviruses, adenoviruses, and
common bacterial and parasitic pathogens as previously described [85].
RT-PCR assays were used to screen specimens for the presence of
caliciviruses and astroviruses [85,126] .

Seattle Cohort. Specimens were tested for the presence of a number of
bacterial species (Campylobacter jejuni, Escherichia coli O157:H7 and
non-O157:H7 Shiga toxin-producing E. coli, Salmonella, Shigella, and
Yersinia) following standard culture assays, Clostridium difficile toxin by a
cytotoxicity assay, parasites by microscopy and antigen testing [84].
Additionally, samples were tested by EIA for rotaviruses, adenoviruses,
noroviruses 1 & 2, and astroviruses (Meridian Biosciences, DAKO). This study
was approved by the institutional review boards of the CHRMC and of
Washington University.

Library construction and mass sequencing.
Chips of frozen archived fecal specimens (~30-150mg) were resuspended
in 6 volumes of PBS.

A subset of the archived specimens had been
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previously diluted and were further diluted 1:1in PBS. The stool suspensions
were centrifuged (9,700 x g, 10 minutes) and supernatants were harvested
and then passed through 0.45µm filters. RNA was extracted from 100µL of
the filtrates using RNA-Bee (Tel Test, Inc., Friendswood, Texas) according to
manufacturers instructions. Approximately, 100-300 nanograms of RNA
from each sample was randomly amplified following the Round AB
protocol as previously described [41]. The amplified nucleic acid was
cloned into pCR4 using the TOPO cloning kit (Invitrogen, Carlsbad, CA),
and transformed into Top10 bacteria. Positive colonies were subcloned
into 384 well plates, DNA was purified using magnetic bead isolation, and
followed by sequencing using standard Big Dye terminator (v3.1)
sequencing chemistry and the universal primer M13 reverse. Reactions
were ethanol precipitated and resuspended in 25uL of water prior to
loading onto the ABI 3730xl sequencer.

Analysis of sequence reads.
Sequence traces were subjected to quality assessment and base-calling
using Phred [127,128]. Lucy [129] was used to trim vector and low quality
sequences. Default parameters were used except that high quality
sequences identified by Lucy were allowed to be as short as 75
nucleotides. To define the set of reads with unique sequence content in
each library, sequences that passed the quality filter were clustered using
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BLASTClust from the 2.2.15 version of NCBI BLAST to eliminate redundancy.
Sequences were clustered based on 98% identity over 98% sequence
length, and the longest sequence from each cluster was aligned to the
NCBI nr database using the tBLASTx algorithm [130]. An E-value cutoff of
1e-5 was applied.

Sequences were phylotyped as human, bacterial,

phage, viral, or other based on the identity of the best BLAST hit.
Sequences without any hits having an E-value of 1e-5 or better were
placed in the “Unassigned” category. All eukaryotic viral sequences were
further classified into viral families in similar fashion.
Trimmed, high quality sequences that were not found by RepeatMasker to
contain repetitive or low-complexity sequence have been deposited in
Genbank (Accession numbers ET065304 through ET067293).

Phylogenetic analysis.
ClustalX (1.83) was used to perform multiple sequence alignments of the
protein sequences associated with select sequence reads. Available
nucleotide or protein sequences from known viruses were obtained from
Genbank for inclusion in the phylogenetic trees.

Selected sequences

from Genbank included those with the greatest similarity to the sequence
read in question based on the BLAST alignments as well as representative
sequences from all major taxa within the relevant virus family. The protein
alignments created by ClustalX were input into PAUP [118], and maximum
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parsimony analysis was performed using the default settings with 1,000
replicates.

Astrovirus trees: Human astrovirus 1 (NC_001943); Human astrovirus 2
(L13745); Human astrovirus 3 (AAD17224); Human astrovirus 4 (DQ070852);
Human astrovirus 5 (DQ028633); Human astrovirus 6 (CAA86616); Human
astrovirus 7 (AAK31913); Human astrovirus 8 (AF260508); Turkey astrovirus 1
(Y15936); Turkey astrovirus 2 (NC_005790); Turkey astrovirus 3 (AY769616);
Chicken astrovirus (NC_003790); Ovine astrovirus (NC_002469); and Mink
astrovirus (NC_004579).

Nodavirus tree: Striped Jack Nervous Necrosis virus (Q9QAZ8);
Macrobrachium rosenbergii nodavirus (Q6XNL5); Black Beetle virus
(YP_053043.1); Flockhouse virus (NP_689444.1); Epinephelus tauvina
nervous necrosis virus (NC_004136.1); Nodamura virus (NC_002691.1);
Boolarra virus (NC_004145.1); Pariacoto virus (NC_003692.1); and
Redspotted grouper nervous necrosis virus (NC_008041.1).

Picornavirus trees: Human coxsackievirus A1 (AAQ02675.1), Human
coxsackievirus
A18
(AAQ04836.1),
Human
coxsackievirus
A19
(AAQ02681.1), Human coxsackievirus A21 (AAQ04838.1), Human
coxsackievirus A24 (ABD97876.1), Human poliovirus 1 (CAD23059.1),
Human coxsackievirus A2 (AAR38840.1), Human coxsackievirus A4
(AAR38842.1), Human coxsackievirus A5 (AAR38843.1), Human
coxsackievirus A16 (AAV70120.1), Human enterovirus 89 (AAW30683.1),
Human enterovirus 91 (AAW30700.1), Human enterovirus 90 (BAD95475.1),
Human enterovirus 71 (CAL36654.1), Echovirus 1 strain Farouk
(AAC63944.2), Human coxsackievirus B2 (AAD19874.1), Human enterovirus
86 (AAX47040.1), Human coxsackievirus B5 (AAF21971.1), Human
echovirus 29 (AAQ73089.1), Human enterovirus 68 (AAR98503.1), Human
enterovirus 70 (BAA18891.1), Bovine enterovirus (NP_045756.1), Porcine
enterovirus A (NP_653145.1), Porcine enterovirus B (NP_758520.1), Simian
enterovirus A (NP_653149.1), Human rhinovirus A (ABF51203.1), Human
rhinovirus B (NP_041009.1).

Picobirnavirus trees: Human picobirnavirus strain 1-CHN-97 (AF246939.1),
Human picobirnavirus strain 4-GA-91 (AF246940.1), Human picobirnavirus
strain Hy005102 (NC_007027.1), Human picobirnavirus strain 2-GA-91
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(AF245701.1), Human picobirnavirus strain 1-GA-91 (AF246612.1), Porcine
picobirnavirus 2 (EU104360.1).

Anellovirus trees: TGP96 Torque teno virus (AB041962), Pt-TTV8-II Torque
teno virus (AB041963), CBD231 TTV-like mini virus (AB026930), Mf-TTV9
Torque teno virus (AB041959), Mf-TTV3 Torque teno virus (AB041958),
KC009/G4 Torque teno virus (AB038621), TA278/G1 Torque teno virus
(AB008394), Pt-TTV6 Torque teno virus (AB041957), TUS01/G3 Torque teno
virus (AB017613), PMV/G2 Torque teno virus (AF261761), JT33F/G5 Torque
teno virus (AB064606), MD1-073 Torque teno midi virus (AB290918), MD2013 Torque teno midi virus (AB290919),
Tbc-TTV14 Torque teno virus
(AB057358), Sd-TTV31 Torque teno virus (AB076001), Fc-TTV4 Torque teno
virus (AB076003), Cf-TTV10 Torque teno virus (AB076002), So-TTV2
Torque
teno virus (AB041960), At-TTV3 Torque teno virus (AB041961).

Calicivirus trees: Camberwell (AAD33960.1), MD-2004 (ABG49508.1),
Carlow(ABD73935.1), Snow Mountain virus (AAN08111.1), Mc37
(AAS47823.1), Hawaii(AAB97767.2), Norwalk(AAB50465.1), Southampton
(AAA92983.1), Chiba(BAB18266.1), Hesse(AAC64602.1), BoJena-DEU-98
(CAA09480.1), Murine (AAO63098.2), SU17(BAC11827.1), Dumfries
(AAM95184.2), SU25-JPN(BAC11830.1), SU1-JPN(BAC11815.1), Desert Shield
(AAA16284.1), Melksham (CAA57461.1), Toronto-24 (AAA18929.1), Sw918
(BAB83515.1), OH-QW101 (AAX32876.1).

Endonuclease-like sequences for D03 tree (mimvirus-like sequences):
Bacteroides
caccae
(ZP_01959575.1),
Acanthamoeba
mimivirus
(YP_142599.1), Eubacterium dolichum (ZP_02077753.1), Staphylococcus
phage K (YP_024462.1), Lactobacillus phage LP65 (YP_164778.1),
Lactococcus phage bIL170 (NP_047162.1), Lactococcus phage r1t
(NP_695069.1),
Burkholderia
vietnamiensis
G4
(YP_001119011.1),
Streptococcus pyogenes (NP_607538.1), Tetrahymena thermophila
(XP_001029162.1), Bacteroides vulgatus (YP_001300673.1)
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Supplemental Figures:

Supplemental Figure 2.S1: Phylogenetic analysis of picobirnavirus-like sequence reads.
Phylogenetic trees were generated by comparing the translated amino acid sequence
of individual sequence reads to members of the unclassified taxa picobirnavirus. The
trees were created using the maximum parsimony method with 1,000 replicates.
Bootstrap values over 700 are shown.

Supplemental Figure 2.S2: Phylogenetic analysis of Picornaviridae-like sequence reads.
Phylogenetic trees were generated by comparing the translated amino acid sequence
of individual sequence reads to members of the Picornaviridae family. The trees were
created using the maximum parsimony method with 1,000 replicates. Bootstrap values
over 700 are shown. CVA=Coxsakievirus A, CVB=Coxsackievirus B, BEV=Bovine Enterovirus,
EV=Enterovirus, HRVA=Human Rhinovirus A, HRVB=Human Rhinovirus B, PEV=Porcine
Enterovirus, PV=Poliovirus, SEVA=Simian Enterovirus A.
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Supplemental Figure 2.S3: Phylogenetic analysis of anellovirus-like sequence reads.
Phylogenetic trees were generated by comparing the translated amino acid sequence
of individual sequence reads to Anelloviruses. The trees were created using the maximum
parsimony method with 1,000 replicates. Bootstrap values over 700 are shown.
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Supplemental Figure 2.S4: Phylogenetic analysis of Caliciviridae-like sequence reads.
Phylogenetic trees were generated by comparing the translated amino acid sequence
of individual sequence reads to the A) NS4 (3A-like) protein or B) NS7 (RNAP) protein of
Caliciviruses. The trees were created using the maximum parsimony method with 1,000
replicates. Bootstrap values over 700 are shown.
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Supplemental Figure 2.S5: Phylogenetic analysis of endonuclease-like sequence reads.
Phylogenetic trees were generated by comparing the translated amino acid sequence
of two individual sequence reads to endonuclease sequences derived from mimivirus,
phage, and bacterial species representing some of the top scoring BLAST hits. The trees
were created using the maximum parsimony method with 1,000 replicates. Bootstrap
values over 700 are shown.
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ABSTRACT
Astroviruses infect a variety of mammals and birds and are causative
agents of diarrhea in humans and other animal hosts.

We have

previously described the identification of several sequence fragments with
limited sequence identity to known astroviruses in a stool specimen
obtained from a child with acute diarrhea, suggesting that a novel virus
was present. In this study, the complete genome of this novel virus isolate
was sequenced and analyzed. The overall genome organization of this
virus paralleled that of known astroviruses, with 3 open reading frames
identified. Phylogenetic analysis of the ORFs indicated that this virus is
highly divergent from all previously described animal and human
astroviruses.

Molecular features that are highly conserved in human

serotypes 1-8, such as a 3’NTR stem-loop structure and conserved
nucleotide motifs present in the 5’NTR and ORF1b/2 junction, were either
absent or only partially conserved in this novel virus.

Based on the

analyses described herein, we propose that this newly discovered virus
represents a novel species in the family Astroviridae. It has tentatively
been named Astrovirus MLB1.

BACKGROUND
Astroviruses are non-enveloped, single stranded, positive sense RNA
viruses. Their genomes range from approximately 6 to 8 kb in length, are
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polyadenylated, and have both 5’ and 3’ non-translated regions (NTR)
[131]. Their genomes have three open reading frames (ORFs) organized
from 5’ to 3’ as follows: ORF 1a, which encodes a serine protease; ORF1b,
which encodes the RNA dependent polymerase; and ORF 2, which
encodes the structural proteins. A frameshift must occur during the
translation of ORF1a in order for ORF1b to be translated.

ORF 2 is

translated from a sub-genomic RNA and produces a polyprotein which is
cleaved by cellular proteases [131].
The family Astroviridae includes 8 closely related human serotypes
as well as additional members that infect cattle, sheep, cats, dogs, deer,
chickens, turkeys, and ducks [102]. Although some of the animal
astroviruses are known to cause hepatitis or nephritis [104], astroviruses
typically cause diarrhea in their hosts. Human astrovirus infections most
frequently cause watery diarrhea lasting 2-4 days, and less commonly
vomiting, headache, fever, abdominal pains, and anorexia in children
under the age of 2, the elderly, and immunocompromised individuals
[104]. The known human astroviruses account for up to ~10% of sporadic
cases of non-bacterial diarrhea in children [84,85,105,132,133].
Diarrhea is the third leading infectious cause of death worldwide
and is responsible for approximately 2 million deaths each year as well as
[80] an estimated 1.4 billion non-fatal episodes [81,82].

In children,

rotaviruses, caliciviruses, adenoviruses and astroviruses are responsible for
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the greatest proportion of cases [84-88]. Most epidemiological studies fail
to identify an etiologic agent in ~40% of diarrhea cases [89-93]. Recently,
we conducted viral metagenomic analysis of diarrhea samples using a
mass sequencing approach with the explicit goal of identifying novel
viruses that may be candidate causes of diarrhea. One of the stool
samples we analyzed was collected in 1999 at the Royal Children’s
Hospital in Melbourne, Australia from a 3-yr old boy with acute diarrhea.
Seven sequence reads were identified in this sample that shared ≤ 67%
amino acid identity to known astrovirus proteins, suggesting that a novel
astrovirus was present in the sample [134]. In this paper, we report the full
sequencing and characterization of the genome of this astrovirus, referred
to hereafter as astrovirus MLB1 (AstV-MLB1).

RESULTS/DISCUSSION
Genome sequencing and analysis. In the previous metagenomic
study [134], we identified seven sequence reads with limited identity to
known astroviruses that could be assembled into two small contigs in a
clinical stool sample. The contigs had 42-44%, and 59-61% amino acid
identity to human astrovirus serine proteases and RNA-polymerases,
respectively. In this study, the complete genome of the astrovirus present
in the original stool specimen was sequenced to an average of >3X
coverage [GenBank: FJ222451]. The virus has been tentatively named
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Astrovirus MLB1 (AstV-MLB1). Analysis of the genome showed that AstVMLB1 has the same genomic organization as other astroviruses. Like other
astroviruses, the AstV-MLB1 genome was predicted to encode three open
reading frames (ORF1a, ORF1b, and ORF2) and contained both 5’ and 3’
non-translated regions (NTR), as well as a poly-A tail. The complete
genome length of AstV-MLB1 was 6,171bp, excluding the poly-A tail,
slightly shorter when compared to other astrovirus genomes which range
in size between ~6,400 and 7,300bp [131]. A comparison of AstV-MLB1
genomic elements with those of fully sequenced astroviruses is shown in
Table 3.1.
The ORF 1a of astroviruses encodes a non-structural polyprotein which
contains a serine-like protease motif. Pfam analysis revealed a region of
ORF1a that has homology to a peptidase domain. In addition, alignment
of AstV-MLB1 with other astroviruses revealed that AstV-MLB1 contains the
amino acids of the catalytic triad (His, Asp, Ser) which are conserved in
the 3C-like protease motif found in other viruses (data not shown) [135].
The residues RTQ which have been suggested to be involved in substrate
binding are conserved among the human astroviruses, but vary in other
viruses which have the 3C-like motif [135]. In AstV-MLB1, the predicted
substrate binding residues (ATR) are identical to those found in Ovine
astrovirus and not those of the human astroviruses (data not shown).
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Table 3.1: Genome Comparison of MLB1 to other astroviruses
Genome
5' UTR
Virus
(bp)
(bp)
ORF1a ORF1b ORF2

3' UTR

Chicken AstV-1

6,927

15

3,017

1,533

2,052

305

Turkey AstV-1
Turkey AstV-2
Mink AstV
Ovine AstV

7,003
7,325
6,610
6,440

11
21
26
45

3,300
3,378
2,648
2,580

1,539
1,584
1,620
1,572

2,016
2,175
2,328
2,289

130
196
108
59

Human AstV-1
Human AstV-2
Human AstV-4
Human AstV-5
Human AstV-8

6,813
6,828
6,723
6,762
6,759

85
82
84
83
80

2,763
2,763
2,763
2,763
2,766

1,560
1,560
1,548
1,548
1,557

2,361
2,392
2,316
2,352
2,349

80
82
81
86
85

AstV-MLB1

6,171

14

2,364

1,536

2,271

58

A second feature of astrovirus ORF1a is the presence of a bipartite
nuclear localization signal (NLS) found in human, chicken, and ovine
astroviruses, but not turkey astroviruses [136]. A bipartite NLS is
characterized as having two regions of basic amino acids separated by a
10 aa spacer. The protein alignment of ORF1a revealed that AstV-MLB1
has a sequence motif similar to the putative NLS of human astroviruses.
This region of the genome has also been predicted to potentially encode
for a viral genome-linked protein (VPg) [137]. The high sequence similarity
observed between AstV-MLB1 and other astroviruses in the motifs
identified as essential for a putative VPg suggests that AstV-MLB1 may also
encode a VPg (data not shown). While no experimental data exists
supporting the prediction of the presence of a Vpg being encoded in any
of the astrovirus genomes, we should note that we did encounter difficulty
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in obtaining the 5’ end of the MLB1 genome until treatment of the RNA
with proteinase K prior to RNA extraction was added to the experimental
protocol.
Finally, the 2,364nt sequence of AstV-MLB1 ORF1a is shorter than
ORF1a sequences of other astroviruses, which range between ~2,5003,300nt (Table 3.1). The shorter length of AstV-MLB1 ORF1a relative to the
human astroviruses is largely attributable to two deletions totaling 57
amino acids located within a highly conserved motif near the carboxyl
terminus of human astroviruses 1-8. This deletion falls within a 144 aa region
that has been mapped as being an immunoreactive epitope in human
astroviruses [138] and is located in the non-structural protein p38 [135].
Recently, p38 has been reported to lead to apoptosis of the host cell
which results in efficient virus replication [139] and particle release [140].
However, it is unclear how the genome deletion identified in AstV-MLB1
might influence these activities.
Astrovirus ORF1b is classically generated by a -1 ribosomal frameshift
induced by the

presence

of a heptameric

‘slippery sequence’

(AAAAAAAC). [102]. A conserved slippery sequence was identified near
the end of ORF1a of Ast-MLB1 and FSFinder was used to determine if the
downstream sequence was capable of forming a stem-loop structure, as
found in other astoviruses [141]. The predicted start position of ORF1b was
then determined by selecting the first amino acid in frame with the
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slippery sequence. The 1b open reading frame of astroviruses encodes an
RNA-dependent RNA polymerase (RNAP). Pfam analysis revealed that
AstV-MLB1 ORF1b contains the RNA-dependent RNA polymerase domain
found in other positive strand RNA viruses, suggesting this ORF does in fact
encode for an RNAP.
Astrovirus ORF2 encodes a large structural polyprotein that is
cleaved by cellular proteases to generate the viral capsid proteins.
Following the convention of human astroviruses [142,143] by choosing a
start codon for ORF2 located two nucleotides upstream of the ORF 1b
stop codon resulted in a predicted protein length of 756aa. Pfam analysis
of the predicted protein encoded by ORF2 identifies an astrovirus capsid
motif, thereby congruent with the paradigm of astrovirus genome
organization in which ORF2 encodes the structural capsid proteins.
The AstV-MLB1 ORF2 protein sequence was divided into four
subregions for more detailed analysis as described [144]. Pair-wise
comparisons of each region were conducted between the AstV-MLB1
sequence and the sequences of all astroviruses for which sequences were
available. Consistent with previous reports, region I appeared to be the
most conserved of the four regions and in each of the regions, AstV-MLB1
shared the most similarity to known human astroviruses. However, even in
region I, AstV-MLB1 only exhibited 33-35% identity to known human
astroviruses. In the less conserved regions II-IV, AstV-MLB1 shared only 5-
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27% amino acid identity to the known human astroviruses. By contrast, the
range of identities between human astrovirus serotypes 1-8 were, 43-75%,
16-66% and 28-77% for regions II, III and IV, respectively. Overall, ASTVMLB1 maintained higher conservation in region I of ORF2 than in other
regions, consistent with paradigms established by analysis of other
astroviruses.

Non-coding features.
Multiple independent 5’ RACE experiments were performed to
determine the precise 5’ end of the genome.

Based on these

experiments, the AstV-MLB1 5’ NTR was determined to be 14nt long. This is
similar in length to the ~10-20nt 5’NTRs of avian astroviruses [131], but
much shorter than the 80-85 nt long 5’NTRs of the 8 human astrovirus
serotypes (Table 3.1). Notably, the human astroviruses share a 20nt
consensus sequence at the terminal 5’ nucleotides of the genome which
is not conserved in other astroviruses (data not shown). AstV-MLB1
contained 13 out of the 20 consensus nucleotides, including the most
5’CCAA motif within the this region [145] (Figure 3.1A). These data support
the notion that the sequence we generated does contain the very 5’
terminus of the genome.
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Figure 3.1: Multiple sequence alignments of putative astrovirus regulatory regions.
A.) Alignment of the 20 nucleotides at the very 5’ end of the Astrovirus MLB1 genome
with those of fully sequenced astroviruses. MLB1 only shares 13 of the 20 conserved
nucleotides present in human strains 1-8. B.) Alignment of the 52nt highly conserved
nucleotide motif (shown in box) present immediately upstream of the ORF1b/ORF2
junction of Astrovirus MLB1 and other astroviruses. (Note: there is no overlap in the Turkey
Astroviruses). MLB1 lacks the high degree of sequence identity seen between the human
astroviruses. The start codon of ORF2 is shown underlined and the stop codon of ORF1b is
shown italicized in bold for each virus.

Human astroviruses contain a 120nt region at the junction between
ORF1b and ORF2 that is ~95-97% conserved between serotypes [146]. The
most highly conserved core 52nt region of this sequence is 99-100%
identical among the human astrovirus serotypes. The exact role of this
sequence is not known, but it is hypothesized to be a regulatory element
of the sub-genomic RNA that encodes for ORF2. Alignment between AstVMLB1 and other human astroviruses of the highly conserved 52nt at the
ORF1b/ORF2 junction revealed that AstV-MLB1 possessed only 61.5%
identity in this region (Figure 3.1B).

By contrast, the known animal

astroviruses share only 44-59.6% identity in this 52nt region with human
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astroviruses as determined by pair-wise comparisons. Interestingly, AstVMLB1 shares 71.2% identity in this region to Ovine Astrovirus.
All of the previously described astroviruses, with the exception of
turkey astrovirus 2, have a conserved RNA secondary structure referred to
as the stem-loop II-like motif (s2m) found at the 3’ end of the genome in
the 3’ NTR [42]. This motif is also present in some coronaviruses and equine
rhinovirus

serotype

2.

Mutations

within

this

motif

are

generally

accompanied by compensatory mutations that restore base pairing [42].
The conservation of such a sequence motif across multiple viral families
suggests that it may play a broad role in the biology of positive stranded
RNA viruses [42]. The exact function of this stem loop is not known, but it is
hypothesized to interact with viral and cellular proteins needed for RNA
replication. Nucleotide alignment of the 150 nucleotides at the 3’ terminus
of the AstV-MLB1 genome and other viruses known to contain the stemloop motif suggested that AstV-MLB1 does not have this conserved
nucleotide motif (data not shown). Furthermore, it also has the shortest
3’NTR reported to date for an astrovirus. (Table 3.1) [131].
Phylogenetic analysis.

Multiple sequence alignments of the three

astrovirus open reading frames were performed and bootstrapped
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maximum parsimony trees were
generated (Figure 3.2). The trees
confirmed initial assessments that
AstV-MLB1

is

a

novel

astrovirus[134]. The trees for ORFs
1a and 1b (Figure 3.2A, B) both
indicated that AstV-MLB1 is most
closely related to the human
astroviruses, although it is highly
divergent from them. AstV-MLB1
ORF1a only has 9-28% amino acid
identity to other astrovirus ORF1a
proteins

and

the

pairwise

sequence alignments of ORF1b
revealed

35-54%

amino

acid

identity between ORF1b proteins
of

AstV-MLB1

and

other

astroviruses (Table 3.2).
Figure 3.2: Phylogenetic analysis of AstVMLB1 open reading frames.
Phylogenetic trees are based on amino
acid sequences and were generated
using the maximum parsimony method
with
1,000
bootstrap
replicates.
Significant bootstrap values are shown.
(A) ORF1a; (B) ORF1b; (C) ORF2. HAstV = Human astrovirus; CAstV = Chicken astrovirus;
MAstV = Mink astrovirus; TAstV = Turkey astrovirus; OAstV = Ovine astrovirus.
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HAstV-2

HAstV-3

HAstV-4

HAstV-5

HAstV-6

HAstV-7

HAstV-8

TAstV-1

TAstV-2

TAstV-3

ChAstV-1

OAstV

MAstV

ORF
1a
ORF
1b
ORF 2

HAstV-1

Table 3.2: Comparison of astrovirus proteins to predicted AstV-MLB1 proteins.
Est.
Size
(aa)
% Amino Acid Identity to:
Gene

787

28

28

NA

29

29

NA

NA

29

9

9

NA

10

22

24

511
756

54
24

54
24

NA
24

54
23

54
23

NA
24

NA
24

54
24

36
15

35
16

NA
16

36
11

47
18

44
19

The maximum parsimony tree for ORF2 (Figure 3.2C) shows that there is
greater divergence among all of the sequences for ORF2, as is to be
expected of the capsid region. However it is still evident that AstV-MLB1 is
quite divergent from any of the known human astroviruses. Based on the
predicted 756aa protein of ORF2, AstV-MLB1 has only 11-24% amino acid
identity to other astrovirus capsid precursor proteins (Table 3.2).
Origin of virus. At this point, the origin of AstV-MLB1 is unclear. AstVMLB1 may be a bona fide human virus capable of infecting and
replicating within the human gastrointestinal tract that had evaded
detection until now.

Alternately, it may be a passenger virus present

simply as a result of dietary ingestion, as has been described previously for
plant viruses detected in human stool [78]. Of course, viruses derived from
dietary intake that appear to cause human disease, such as Aichi virus,
have been described previously [147,148]. Another possibility is that this
virus may represent zoonotic transmission from some other animal species
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that is the true host for Astrovirus MLB1.

Traditionally it has been thought

that astroviruses have a strict species tropism. However, recent evidence
has emerged that suggests that interspecies transmission does occur. For
example, chicken astrovirus antibodies have been detected in turkeys
[149] and an astrovirus was isolated from humans whose capsid sequence
most closely resembled that of feline astrovirus[131]. Because of the
uncertainty as to the identity of the true host species and the host range
for this virus, we have tentatively named this novel virus Astrovirus MLB1
(AstV-MLB1).

Efforts to define whether AstV-MLB1 is a novel human

pathogen are underway.

CONCLUSION
Complete sequencing and genome analysis of Astrovirus MLB1
revealed that the virus has three open reading frames sharing the same
organization as other astroviruses. Phylogenetic analysis of the open
reading frames clearly demonstrated that AstV-MLB1 is highly divergent
from any of the known astroviruses. Furthermore, AstV-MLB1 lacks the
conservation seen between human astroviruses 1-8 in the non-translated
regions of the genome such as the 5’ and 3’ NTR and the ORF1b/2
junction. The aggregate analysis of the non-coding features and ORFs as
well as the phylogentic analysis clearly indicates that AstV-MLB1 is highly
divergent from all previously described astroviruses.
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The divergence of AstV-MLB1 from known astroviruses in the nontranslated regions of the genome is particularly interesting because these
regions are nucleotide motifs that are thought to play regulatory roles in
viral replication. This suggests that AstV-MLB1 may behave very differently
from the known astroviruses and that additional studies on the regulation
of

AstV-MLB1

transcription

and

replication

may

broaden

our

understanding of astrovirus paradigms.
Astroviruses are associated with diarrhea predominantly in young
children and immunocompromised individuals.

The discovery of AstV-

MLB1 in a liver transplant patient fits well with the known clinical
parameters of astrovirus infection. We previously reported that the only
other virus detected in this stool was a TT virus [134], which is thought to be
non-pathogenic [150]. It is therefore tempting to speculate that AstV-MLB1
is the pathogenic agent that caused this case of diarrhea. However,
whether AstV-MLB1 is a bona fide human virus capable of causing
diarrhea will have to be established by further experimentation and
epidemiological surveys.

Materials and Methods
Specimen. A stool sample was collected from a 3 year old boy admitted
to the Royal Children’s Hospital with acute diarrhea in 1999. The child had
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previously undergone a liver transplant one year prior to this episode of
diarrhea, however the immunological status was unknown.

RNA extraction. RNA was isolated from the primary stool filtrate using RNABee (Tel-Test, Inc.) according to manufacturer’s instructions. In some cases,
the stool filtrate was treated with 2.5 mg\ml proteinase K (Sigma) for 30
min prior to RNA extraction.

Genome amplification and sequencing. The astrovirus sequence reads
previously detected in the primary stool filtrate

[134] [GenBank

accessions: ET065575, ET065576, ET065577, ET065579, ET065580, ET065581,
ET065582] were assembled into two contigs, and the nucleic acid
between the contigs was obtained by RT-PCR. For reverse transcription
reactions, cDNA was generated with MonsterScript RT at 65ºC and
amplified with Taq (Invitrogen).

Subsequent 5’ and 3’ RACE reactions

were done to obtain the entire genome.

To generate high quality

sequence coverage, 7 pairs of specific primers that spanned the
complete genome in overlapping ~1kb fragments were used in RT-PCR
reactions and then cloned and sequenced using standard Sanger
sequencing chemistry.

All amplicons were cloned into pCR4.0

(Invitrogen). These 7 primer pairs were used to confirm the sequence of
the viral genome from both the primary stool sample and the passage 2
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tissue culture sample. The complete genome sequence of AstV-MLB1 has
been deposited in [GenBank: FJ222451].

ORF prediction and annotation.

Open reading frames 1a and 2 were

predicted for AstV-MLB1 using the NCBI ORF Finder program. ORF1b was
predicted based on the frameshift paradigm that occurs in other
astroviruses by identifying a heptameric slippery sequence [151].
Conserved motifs were identified using Pfam [152].

Pair-wise alignments. Bioedit was used to determine the percent identity
between sequences as determined by pair-wise alignments.

Phylogenetic analysis. ClustalX (1.83) was used to carry out multiple
sequence alignments of the protein sequences associated with all three
of the open reading frames of representative astrovirus types. Maximum
parsimony trees were generated using PAUP with 1,000 bootstrap
replicates [118].
Available nucleotide or protein sequences of the following astroviruses
were obtained: Human Astrovirus 1 [GenBank: NC_001943]; Human
Astrovirus 2 [GenBank: L13745]; Human Astrovirus 3 [GenBank: AAD17224];
Human Astrovirus 4 [GenBank: DQ070852]; Human Astrovirus 5 [GenBank:
DQ028633]; Human Astrovirus 6 [EMBL: CAA86616]; Human Astrovirus 7
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[Gen Bank: AAK31913]; Human Astrovirus 8 [GenBank: AF260508]; Turkey
Astrovirus 1 [GenBank: Y15936]; Turkey Astrovirus 2 [GenBank: NC_005790];
Turkey Astrovirus 3 [GenBank: AY769616]; Chicken Astrovirus [GenBank:
NC_003790]; Ovine Astrovirus [GenBank: NC_002469]; and Mink Astrovirus
[GenBank: NC_004579].
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ABSTRACT
The prevalence of the recently identified astrovirus MLB1 in a
pediatric diarrhea cohort in St. Louis, USA was defined by RT-PCR. Of 254
stool specimens collected in 2008, 4 were positive for astrovirus MLB1.
These results demonstrate that astrovirus MLB1 is currently circulating in
North America.

BACKGROUND
Astroviruses infect a variety of hosts including humans, turkeys,
chicken, cattle, sheep, dogs, cats, deer, ducks and bats [102,103]. There
are 8 known human serotypes which are genetically very closely related.
Astroviruses typically cause diarrhea in their hosts and in humans
symptoms normally last 2-4 days [104]. Children under the age of 2, elderly
people,

or

otherwise

immunocompromised

individuals

are

most

commonly affected [104]. Epidemiological studies suggest Human
astroviruses 1-8 are responsible for up to ~10% of cases of acute, nonbacterial diarrhea in children [84,85,105,132,133].
Recently, a highly divergent astrovirus, referred to as astrovirus
MLB1 (AstV-MLB1), was identified in the stool of a three year old boy in
Australia [134]. The entire genome of this novel virus was subsequently
sequenced and characterized [153] . To date, there have been no
published reports describing the presence of AstV-MLB1 outside of the
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index case. In this study, the prevalence of this novel virus was determined
by RT-PCR screening of pediatric stool samples collected at the St. Louis
Children’s Hospital in St. Louis, MO, USA.

RESULTS/DISCUSSION
Pediatric stool specimens sent to the clinical microbiology lab for
bacterial culture at the Saint Louis Children’s Hospital were analyzed for
the presence of AstV-MLB1.

This study was approved by the Human

Research Protection Office of Washington University in St. Louis. Samples
were collected January-May of 2008. Stools were diluted in PBS at a 1:6
ratio (w/v) and total nucleic acid (TNA) was extracted from 200µL of each
stool suspension using the MagNAPure LC Automated Nucleic Acid
Extraction System (Roche).
Previously described astrovirus primers Mon269 and Mon270 [154]
have frequently been used for the detection of human astrovirus
serotypes 1-8 in clinical stool specimens. However, the extensive
divergence of AstV-MLB1 to the known human astroviruses rendered these
primers unable to amplify AstV-MLB1 (data not shown). Since it is possible
that AstV-MLB1 represents a new grouping of astroviruses that could
include multiple subtypes, we designed primers to conserved regions of
the AstV-MLB1 genome in order to maximize the likelihood of detection of

- - 93 - -

Figure 4.1: Astrovirus ORF1b alignments for design of pan-astrovirus primers
Astrovirus RNA polymerase sequences (ORF1b) were aligned at the amino acid level in
order to define the conserved regions used for the design of primers SF0073 (A) and
SF0076 (B). The numbers to the right of the sequences indicate the position of the last
amino acid within each ORF1b sequence. The amino acids outlined in the red boxes
represent the specific regions that were reverse translated into the corresponding
nucleic acid sequences used for the design of SF0073 (C) and SF0076 (D). The red
sequences shown in the nucleotide alignments are the actual primer sequences for
SF0073 (C) and SF0076 (D).

any AstV-MLB1 variant viruses, or even other novel astroviruses. Conserved
regions were identified by performing multiple sequence alignments of
AstV-MLB1 amino acid sequences to all fully sequenced astrovirus
genomes (Figure 4.1A, 4.1B). The corresponding nucleotide sequences for
these regions were then aligned in order to define the most highly
conserved regions (Figure 4.1C, 4.1D). Two regions within ORF 1b were
identified that yielded primers SF0073 (5’GATTGGACTCGATTTGATGG) and
SF0076 (5’CTGGCTTAACCCACATTCC) that are predicted to generate a
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~409 bp product.

Control experiments validated that this primer pair

could detect AstV-MLB1 as well as Human astrovirus 1 (Figure 4.2). Given
that some of the canonical human astroviruses are identical in the primer
binding sites, this data suggests that at least some of the canonical
human astroviruses can be detected by the primer pair SF0073/SF0076. In
theory, under appropriate experimental conditions, these primers may
also be able to detect all other known human and animal astroviruses,
although that remains to be experimentally tested. These primers were
used with the QIAGEN One-Step RT-PCR kit using the following cycling
conditions: 30 min RT step, 94ºC hold for 10 min, followed by 40 cycles of
94ºC for 30s, 52ºC for 30s, and 72ºC for 50s.

Figure 4.2: Validation of screening
primers SF0073 and SF0076
Primers SF0073 and SF0076 were tested
on stool filtrate made from the original
AstV-MLB1 positive stool (Lane 2) as well
as a Human astrovirus 1 positive stool
specimen (Lane 3) using the QIAGEN
One-Step RT-PCR kit as described in the
text. The products were visualized on a
1.2% agarose gel. The expected size of
the RT-PCR product generated with
these primers is ~400bp. Lane 1 shows
the Invitrogen 100bp DNA ladder for a
size comparison.

Samples that tested positive with primers SF0073 and SF0076 were
then tested in a second round of screening with two different primer sets
in parallel to determine if the samples contained canonical human
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astrovirus serotypes 1-8 or AstV-MLB1. The previously reported Mon269
(5’CAACTCAGGAAACAGGGTGT)
(5’TCAGATGCATTGTCATTGGT)

primers,

and
which

generate

Mon270
a

449

bp

amplicon, were used to detect canonical human astroviruses [154].
Another set of primers, SF0053 (5’CTGTAGCTCGTGTTAGTCTTAACA) and
SF0061 (5’GTTCATTGGCACCATCAGAAC), was designed to exclusively
detect AstV-MLB1 and produce a 402bp PCR product. These primers
target a region of the capsid gene. The second round of screening with
both sets of primer pairs was performed as described above with the
exception that an annealing temperature of 56ºC was used.
Of 254 stool specimens screened, 9 (3.5%) tested positive in the
initial round of screening using the newly designed pan-astrovirus primers,
SF0073 and SF0076. Secondary screening demonstrated that 5 (2% of all
samples) were canonical human astroviruses. This is likely to be an
underestimate of the astrovirus serotype 1-8 prevalence in the cohort
since the initial screening primers were biased towards the detection of
AstV-MLB1. The remaining 4 (1.6% of all samples) were positive for AstVMLB1 using primers SF0053 and SF0061. For each of the 4 samples positive
for AstV-MLB1, two additional fragments were generated by RT-PCR for
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Figure 4.3: Phylogenetic Analysis of AstV-MLB1 isolates
A region of the serine protease (A) and the capsid (B) of each virus detected by the
AstV-MLB1 specific primers was amplified and sequenced. Multiple sequence alignments
were then generated with these sequences and the corresponding regions of known
astroviruses using ClustalX. PAUP was used to generate phylogenetic trees and bootstrap
values (>700) from 1,000 replicates are shown.

phylogenetic analysis. A 1228 bp fragment of ORF1a, which encodes the
serine protease, and a 920 bp fragment of ORF2, which encodes the
capsid proteins, were amplified using AstV-MLB1 specific primers from
each of the 4 samples designated WD0016, WD0055, WD0104, WD0227.
The

primers

used

for

the

ORF1a

fragment

are

SF0080

(5’-

AAGGATAGTGCTGGTAAAGTAGTTCAGA-3’) and SF0094
(5’-CAAGAGCCTTATCAACAACGTA-3’) and the primers used for the
ORF2 fragment are SF0064 (5’-GTAAGCATGGTTCTTGTGGAC-3’) and
SF0098

(5’-TGCATACATTTATGCTGGAAGA-3’).

The

ORF1a

fragments

(Genbank # ’s: FJ227120-FJ227123) from these samples all shared ~92%
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Table 4.1: Similarity of fully sequenced WD0016 genome to MLB1
ORF1a
ORF1b
(Serine
(RNA
ORF2
(Capsid)
Protease)
Polymerase)
Nucleotide identity
between WD0016 and
MLB1

92.60%

93.90%

91.90%

nucleotide identity to the reference astrovirus MLB1 sequence (Genbank
# : FJ222451) and 99% amino acid identity, indicating that most mutations
were synonymous. The ORF2 fragments (Genbank # ’s: FJ227124-FJ227127)
shared ~91-92% nucleotide identity and 95-96% amino acid identity to the
reference astrovirus MLB1 sequence. The 4 positive St. Louis samples
shared ~99% nucleotide identity to each other. The ORF1a and ORF2
sequences were aligned to other astroviruses for which full genome
sequences were available using ClustalX (1.83), and then maximum
parsimony trees were generated using PAUP with 1,000 bootstrap
replicates [118] (Figure 4.3). The entire genome of one of the isolates,
WD0016 (Genbank # : FJ402983 ), was sequenced and was determined to
have 92.6% identity overall to that of AstV-MLB1 based on a pairwise
nucleotide alignment. Table 4.1 shows the identity of WD0016 to the
original MLB1 isolate for each open reading frame of the genome.
Clinical and demographic information of patients with AstV-MLB1
positive stools is shown in Table 4.2. The patients with AstV-MLB1 positive
stools were between the ages of ~4mo-4yrs. All patients had symptoms of
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Table 4.2: Clinical and demographic information of patients with AstVMLB1 positive stools
WD0016
WD0055
WD0104
WD0227
Age (months)
15
17
4
43
Gender
Female
Female
Male
Male
Diarrhea
No*
Yes
Yes
Yes
fever, seizures,
Other
abdominal
vomiting,
respiratory
fever
Symptoms
pain
fever
distress
Hospitalization
Yes
No
Yes
Yes
Positive for
Bacterial
Negative
Negative
Negative
E. coli
Cultures†
0157:H7
* Patient had diarrhea two days prior to stool collection, but not at time of collection
† Tests were conducted for E. coli, Campylobacter, Shigella, Salmonella, and Yersinia

diarrhea at the time of stool collection, except for patient WD0016 who
reported having diarrhea 2 days prior to the collection of the stool
specimen. All specimens were tested for the presence of E. coli,
Campylobacter, Yersinia, Shigella, and Salmonella by standard bacterial
culture. WD0227 tested positive for E. coli 0157:H7, while the other samples
were negative for all bacterial cultures. A pan-viral microarray, the
ViroChip [20], was used to examine whether there were other
viruses present in the stool of three (WD0055, WD0104, and WD0227) of the
four AstV-MLB1 positive samples for which there was enough material left
for analysis. WD0055 and WD0104 were negative by array, but WD0227
was positive for rotavirus as determined by the ViroChip.
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CONCLUSIONS
The newly identified AstV-MLB1 virus was discovered in a stool
specimen collected in Melbourne, Australia in 1999.

In this study, we

describe the detection of AstV-MLB1 in a cohort from St. Louis, USA
collected in 2008. This observation provides the first evidence that AstVMLB1 is present outside of Australia, and suggests that AstV-MLB1 is likely to
be globally widespread. In addition, these data demonstrate that AstVMLB1 is currently circulating in the human population.

The observed

sequence divergence of ~8% at the nucleotide level between the
reference AstV-MLB1 genome and the viruses detected in this study
suggests that there may be significant sequence heterogeneity within the
AstV-MLB1 group of viruses.

It is possible that multiple serotypes or

subtypes of AstV-MLB1 exist, as is the case with the canonical human
astroviruses. More extensive screening of stool samples with PCR primers
targeted toward detection of AstV-MLB1 such as those described in this
paper may provide insight into the true diversity and prevalence of AstVMLB1-like viruses.

Finally, a critical direction for future investigation is

determining whether AstV-MLB1, like the canonical astrovirus serotypes 1-8,
is a causal agent of human diarrhea, and if so, what is the disease burden
associated with this virus.

To begin addressing this question, further

epidemiologic studies, including both case-control prevalence studies
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and seroprevalence assays, and efforts to fulfill Koch’s postulates should
be pursued.
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ABSTRACT

Viral gastroenteritis is one of the most common human illnesses worldwide
and is a major cause of morbidity and mortality in infants and young
children. Despite the availability of improved molecular diagnostics to
detect known viral agents, the etiology of a large proportion of diarrheal
cases is unknown. The advent of metagenomic sequencing approaches
has revolutionized the process of pathogen discovery.

In this study,

parallel efforts applying both random Sanger sequencing and high
throughput pyrosequencing were used to analyze fecal specimens
obtained from an outbreak of acute gastroenteritis in a child care center.
The specimens tested negative for known bacterial, parasitic and viral
enteric pathogens by conventional assays.

Sequences consistent with

astroviruses were identified by both techniques, 72 sequence reads by the
low through-put Sanger sequencing and 1339 sequencing reads by high
through-put pyrosequencing. Assembly of these reads into contigs and
subsequent RT-PCR and RACE experiments yielded a complete genome
of 6,586 nucleotides. Phylogenetic analysis of the three predicted open
reading frames from this newly identified astrovirus, tentatively named
Astrovirus VA1 (AstV-VA1), demonstrated that AstV-VA1 was highly
divergent from all previously described human and animal astroviruses
and most closely related to mink and ovine astroviruses.

Using AstV-VA1

specific RT-PCR assays, 3 of 5 fecal specimens from symptomatic
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individuals in this outbreak tested positive, raising the possibility that AstVVA1 may be a causal agent of acute gastroenteritis.

INTRODUCTION
Astroviruses are known to infect a variety of avian and mammalian
species [102,103] and typically cause diarrhea [104]. They are thought to
be host specific with little evidence for cross-species transmission [131]. In
humans, 8 serotypes of astroviruses have been described [131]. Clinical
symptoms usually last 2-4 days and consist of watery diarrhea and, less
commonly, vomiting, headache, fever, abdominal pains, and anorexia
[104].
Astroviruses consist of a family of small, single-stranded, positivesense RNA viruses. Their genomes are organized into three open reading
frames denoted ORFs 1a, 1b, and 2, which encode a serine protease,
RNA-dependent RNA polymerase (RdRP), and a capsid precursor protein,
respectively [131]. At both the 5’ and 3’ ends, non-translated regions (NTR)
flank the 6.1-7.3kb sized genomes [131,153]. Two characteristic features of
astroviruses are the dependency on a ribosomal frameshift for the
translation of ORF1b and the generation of a sub-genomic RNA from
which ORF2 is translated [131].
Human astroviruses have been associated with up to ~10% of
sporadic cases of viral diarrhea in children [84,85,105,132,133] and with
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0.5-15% of outbreaks [94,95,155]. Significantly, in some reports the
etiologies of 12-41% of the outbreaks remain undetermined even after
extensive testing, suggesting that there is a diagnostic gap [94,95].
Similarly, on average, approximately 40% of the cases of sporadic
diarrhea are unexplained [89-93].

In previous efforts to identify novel

candidate pathogens present in sporadic cases of diarrhea in humans,
we used high throughput sequencing to identify a novel astrovirus
(Astrovirus MLB1) [134,153] and a novel picornavirus (Cosavirus E1) [156].
The role of these viruses in causing diarrhea remains unclear. In this paper,
we applied mass sequencing to analyze specimens obtained from an
unexplained outbreak of gastroenteritis. We report the identification and
complete genome sequencing of yet another novel astrovirus, referred to
as Astrovirus VA1 (AstV-VA1), associated with a gastroenteritis outbreak at
a child care center.

RESULTS
Genome sequencing and analysis
Five fecal specimens (labeled A, B, C, D and E) were collected from
a gastroenteritis outbreak at a child care center in Virginia (Table 5.1).
Following high throughput pyrosequencing of RNA and DNA extracted
from samples A, B, C and D (average of 12,730 reads per sample), we
found 313 unique high quality sequence reads in sample B and 1,017
unique high quality reads in sample C most closely related to astroviruses.
- - 105 - -

Table 5.1: Epidemiologic data of the 5 specimens from a child care
center outbreak of acute gastroenteritis.
Sample
Sex
Age
Onset
Sample
Symptoms
ID
Date
Date
A
M
2 years
8/19/08
8/19/08
Diarrhea,
vomiting
B
F
36 years
8/26/08
8/28/08
Diarrhea,
vomiting
C
M
6 months
8/25/08
8/25/08
Diarrhea
D

M

E

Unknown

19
months
20
months

8/5/08

8/26/08

Diarrhea

8/5/08

8/27/08

Diarrhea

A 6,376 nucleotide (nt) contig was assembled from the astrovirus-like
sequences detected in sample B and 4 contigs totaling 6,026 nucleotides
were assembled from sample C. The translated contigs had only limited
sequence similarity (37-71% aa identity) to proteins from mink and ovine
astroviruses, suggesting the presence of a potentially novel astrovirus in
these samples. Because the nucleotide sequences obtained in samples B
and C were nearly identical, the five original contigs were assembled to
generate a larger contig of 6,581 nucleotides in length.
Independently, four of the five fecal samples (stool samples A, B, C
and E) were analyzed by Sanger sequencing. 3 out of 96 clones from
sample B and 69 out of 152 clones from sample C contained sequence
signatures that were most closely related to previously known astroviruses
by Blastn similarity searches. Sequencing of 100 clones each from samples
A and E yielded no clones with detectable similarity to astroviruses. The
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sequences of the 69 clones from sample C were assembled into 4 contigs.
Primers were then designed to generate a series of eight overlapping RTPCR amplicons with an average size of ~900 bp that yielded a genomic
sequence of 6,537 nt. In order to define the 5’ end of the genome, three
independent 5’RACE reactions were performed and a total of 23 clones
from these reactions were sequenced. All clones extended the genome
by 49 nt and yielded the identical 5’end sequence, suggesting that the
genome was complete with a total length of 6,586 nt, excluding the polyA tail.

Comparison of the genome sequences generated by the two

sequencing methods yielded nearly identical sequences, with the
exception of 5 missing nucleotides at the 5’ end of the contig generated
by pyrosequencing and 3 nucleotide substitution differences. These were
resolved by direct PCR sequencing to generate the final, corrected
sequence. This virus has been provisionally named Astrovirus VA1 (AstVVA1).
The genome of AstV-VA1 had three predicted open reading frames
as well as non-translated regions (NTRs) at both the 5’ and 3’ ends of the
genome.

Several conserved protein motifs were identified including a

serine protease in ORF1a, an RNA dependent RNA polymerase in ORF1b,
and capsid protein in ORF 2. ORFs 1a and 2 were predicted by the NCBI
ORF Finder program; however the full coding region for ORF1b was not
predicted by the program because translation of ORF1b is dependent on
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Table 5.2: Genome Comparison of MLB1 to other astroviruses
Genome
5' UTR
Virus
(bp)
(bp)
ORF1a ORF1b ORF2

3' UTR

Chicken AstV-1

6,927

15

3,017

1,533

2,052

305

Turkey AstV-1
Turkey AstV-2
Mink AstV
Ovine AstV

7,003
7,325
6,610
6,440

11
21
26
45

3,300
3,378
2,648
2,580

1,539
1,584
1,620
1,572

2,016
2,175
2,328
2,289

130
196
108
59

Human AstV-1
Human AstV-2
Human AstV-4
Human AstV-5
Human AstV-8

6,813
6,828
6,723
6,762
6,759

85
82
84
83
80

2,763
2,763
2,763
2,763
2,766

1,560
1,560
1,548
1,548
1,557

2,361
2,392
2,316
2,352
2,349

80
82
81
86
85

AstV-MLB1
AstV-VA1

6,171
6,586

14
38

2,364
2,661

1,536
1,575

2,271
2,277

58
98

a -1 ribosomal frameshift that occurs during translation [151]. This
frameshift is thought to be mediated by the presence of a heptameric
‘slippery sequence’ (AAAAAAAC) near the end of ORF1a [151], which
was also conserved in the AstV-VA1 sequence, suggesting that this new
virus

follows

the

same

paradigm.

The

sequence

AUUUGGAGNGGNGGACCNAAN5-8AUGNC located upstream of ORF2,
which has been proposed as the promoter for subgenomic RNA synthesis
in all previously known astroviruses [131], is also present in AstV-VA1 with
only 2 nt differences. The predicted size for each of the open reading
frames is 2,661 nt, 1,575 nt, and 2,277 nt for ORFs 1a, 1b, and 2,
respectively. These sizes are similar to the ORF sizes of mink and ovine
astroviruses (Table 5.2).
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The 5’ non-translated region (NTR) of AstV-VA1 is 38 nt in length,
which is between the lengths of the 5’ NTRs of mink astrovirus (26 nt) and
ovine astrovirus (45 nt). The 3’ NTR is 98 nt in length, which again is
intermediate between the length of the NTRs of ovine astrovirus (59 nt)
and mink astrovirus (108 nt). The 3’ NTR of nearly all astroviruses contains a
highly conserved RNA secondary structure called the stem-loop II-like
motif (s2m), which has also been identified in several coronaviruses and in
equine rhinovirus 2 [42,157]. An alignment of the 150 nt just upstream of
the poly-A tail of AstV-VA1 along with the 3’ terminal sequences of other
astroviruses known to contain the s2m motif indicated that AstV-VA1
contains the highly conserved ~33 nucleotide core of the s2m motif, with
100% identity to other astroviruses in this region. The exact role of this motif
is not understood; however its presence in multiple viral families suggests it
may play an important role in the replication of these viruses.

Phylogenetic analysis
Multiple sequence alignments were independently carried out for
each of the three predicted ORFs. Maximum parsimony trees confirmed
that AstV-VA1 was highly divergent from but most closely related to mink
and ovine astrovirus in all three ORFs (Figure 5.1). Furthermore, the greatest
sequence identity between AstV-VA1 and mink and ovine astroviruses is in
ORF1b with 61% amino acid identity to mink astrovirus and 62% to ovine
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Figure 5.1: Phylogenetic analysis of
AstV-VA1 open reading frames.
Phylogenetic trees were generated in
PAUP using the maximum parsimony
method with 1,000 bootstrap replicates.
Significant bootstrap values are shown.
(A) ORF1a-serine protease; (B) ORF1bpolymerase; (C) ORF2-capsid. HAstV
=Human astrovirus

astrovirus.

The

ORF1a

(serine

protease) coding region was
more divergent with 39% and
40% amino acid identity with
ovine

astrovirus

and

mink

astrovirus, respectively. In ORF2,
AstV-VA1

shared

41%

amino

acid identity to mink astrovirus
and 42% to ovine astrovirus.

RT-PCR screening for AstV-VA1
High

throughput

pyrosequencing yielded many
AstV-VA1 sequences in samples B and C, but none were detected in
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samples A or D. Sample E was not analyzed by pyrosequencing due to
technical problems with the sample preparation. Similarly, Sanger
sequencing detected AstV-VA1 positive reads in samples B and C, but not
in samples A and E (sample D was not initially tested). To determine
whether low levels of AstV-VA1 might be present in samples A, D and E,
real time RT-PCR and semi-nested RT-PCR assays were developed
targeting regions in ORF1b and ORF2, respectively. Using these assays,
sample D tested positive and sequencing of the 250 bp amplicon
confirmed the presence of AstV-VA1.

DISCUSSION
Despite the availability of improved molecular diagnostic methods
for the detection of gastroenteritis viruses in humans such as norovirus,
rotavirus, astrovirus, adenovirus, and sapovirus, the etiology of 12-41% of
the outbreaks of gastroenteritis remain unexplained [94,95], In this study,
we identified a novel astrovirus (AstV-VA1) in fecal samples from an
outbreak of acute gastroenteritis in a child care center by two sequence
independent genome amplification and sequencing methods, high
throughput pyrosequencing and low throughput Sanger sequencing.
Both methods identified and thus confirmed the presence of a novel
astrovirus.
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Complete

genome

sequencing

and

phylogenetic

analysis

demonstrated that AstV-VA1 was highly divergent from all previously
described astroviruses including the 8 human astrovirus serotypes and
recently described astrovirus MLB1 (AstV-MLB1). AstV-VA1 appears to
have diverged from a common ancestor of the mink and ovine
astroviruses following their separation from the branch containing human
astroviruses 1-8 and astrovirus MLB1. The discovery of AstV-VA1 following
the recent identification of AstV-MLB1 clearly demonstrates that a much
greater diversity of astroviruses exists in humans than is commonly
recognized.
The detection of AstV-VA1 in three out of five samples of this
gastroenteritis outbreak suggests a potential association between AstVVA1 and symptomatic infection. The fact that AstV-VA1 was only
detected in sample D by targeted PCR assays and not by either of the
mass sequencing methods may be due to the late timing of sample
acquisition relative to the onset of symptoms (Table 1). Further studies
defining the frequency of detection of AstV-VA1 in additional samples
from individuals with and without acute gastroenteritis are needed to
define the role of AstV-VA1 in human diarrhea. It is likely that the
application of sequence independent amplification and sequencing
methods to other outbreaks of gastroenteritis of unknown etiology will
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identify other novel viruses and expand our ability to determine the cause
of diarrheal disease.

MATERIALS AND METHODS
Outbreak
On Monday, 8/18/2008, the Eastern Shore Health District in Virginia was
notified of cases of gastrointestinal illness among 26 teachers and children
in a child care center over a period of 2 to 3 weeks. Symptoms included
vomiting, and/or diarrhea.

Control measures were put in place

immediately at the center including exclusion of symptomatic children,
mandated testing of all symptomatic staff, testing of symptomatic
children, environmental disinfection of surfaces and ultimately, temporary
closing of the facility. Five fecal specimens (A- E) (Table 5.1) that tested
negative for enteric parasites, enteric bacteria by standard microscopy
and culture, and negative for enteric viruses including rotavirus
(RotaClone EIA), norovirus, sapovirus, human astrovirus, and adenovirus
gp F by (RT)-PCR [92,158,159], were available for further testing.

Genome amplification and Sequencing.
The fecal specimens were further analyzed independently in two
laboratories. At Washington University, the specimens were diluted in PBS
at a 1:6 ratio (w/v) and total nucleic acid was extracted from 200µL of
each fecal suspension using the MagNAPure LC Automated Nucleic Acid
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Extraction System (Roche). Total nucleic acid was randomly amplified
using the Round AB protocol as previously described with the exception
that each sample was independently amplified with a different modified
primer B containing a unique 6-nucleotide barcode at the 5’ end of the
primer [41]. Amplification products from multiple samples were pooled,
adaptor-ligated, and sequenced using the Roche GS-FLX Titanium
platform (Roche) at the Washington University Genome Sequencing
Center.
Sequences from each sample were identified by the unique
barcodes introduced during the Rd B amplification. Primer and barcode
sequences were then trimmed off prior to analysis of the sequences.
Sequences were clustered using CD-HIT [160] to reduce redundancy with
the requirement that they had to be 98% identical over 98% of their
lengths. The longest sequence from each cluster was selected for
inclusion in the pool of unique sequences to be analyzed.

Unique

sequences were filtered for repetitive sequences and compared with the
human genome using BLASTn with an e-value cutoff of 1e-10. Sequences
without significant similarity to the human genome were then compared
to the GenBank nucleic acid nt database using BLASTn (cutoff: 1e-10) and
tBLASTx (cutoff: 1e-5), and remaining sequences without significant hits to
sequences in the database were then compared to the NCBI All Viral
Genome

database

(ftp://ftp.ncbi.nih.gov/refseq/release/viral/)
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using

tBLASTx (cutoff: 1e-5)

[130].

Overlapping sequences with significant

sequence identity were assembled into contigs using Newbler (454 Life
Sciences) or CAP3 [161].
At CDC, 10% fecal suspensions were first clarified by centrifugation
at
6,000×g for 10 minutes and the supernatant was then filtered through a
0.22-um filter (Ultrafree MC; Millipore, Bedford, MA). Total nucleic acid
(TNA) was extracted from 200 µl of the cleared supernatant fluid with the
QIAamp MinElute Virus Spin kit (QIAGEN, Valencia, CA) according to the
manufacturer’s instructions. After elution from the column in 50 µl of
RNase-free water, TNA was randomly amplified using the Round AB
protocol as previously described [41]. The 300-800bp amplicons were then
cloned using the TOPO TA cloning kit (Invitrogen, Carlsbad, CA) and
plasmids were sequenced with a BigDye Terminators v3.1 ready reaction
cycle sequencing kit on an ABI Prism 3130 automated sequencer (Applied
Biosystems, Foster City, CA). Sequence analysis and generation of contigs
were performed using Sequencher software (Ann Arbor, MI, USA).
Sequence identification was performed through NCBI nucleotide–
nucleotide

BLASTn

similarity

searches

(http://www.ncbi.nlm.nih.gov/blast/Blast.cgi). In addition, a set of eight
overlapping RT-PCR products with an average size of 900 bp which cover
the entire genome including the 3’ end poly A tail were generated by
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primer pairs designed from clone sequences as described above, using
the SuperScript III First-Strand Synthesis System for RT-PCR and AccuPrime
High Fidelity Taq DNA polymerase (Invitrogen, Carlsbad, CA, USA). Both
strands of each amplicon were sequenced with a BigDye Terminators v3.1
ready reaction cycle sequencing kit as described above.

The 5’ end

genome sequence was amplified and determined using the 5’ / 3’ RACE
Kit (Roche, Mannheim, Germany) following the manufacturer’s instructions.
The complete genome sequence of AstV-VA1 has been deposited in
Genbank (number will be added once acquired).

ORF Prediction and annotation.
Open reading frames (ORFs) 1a and 2 were predicted by the NCBI
ORF finder (http://www.ncbi.nlm.nih.gov/projects/gorf/). The end of
ORF1b was predicted by the program, however the start of ORF1b was
predicted based on the location of the heptameric slippery sequence
found in other astroviruses [151]. Protein motifs were identified by
conserved domain searches using BlastX and Pfam [152,162-164].

Pair-wise alignments.
Bioedit was used to determine the percent identity between sequences
as determined by pair-wise alignments.
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Phylogenetic analysis.
ClustalX (1.83) was used to carry out multiple sequence alignments of the
protein sequences associated with all three of the open reading frames of
astroviruses for which sequences were available. Maximum parsimony
trees were generated using PAUP with 1,000 bootstrap replicates [118].
Available nucleotide or protein sequences of the following astroviruses
were obtained: Human Astrovirus 1 [GenBank: NC_001943]; Human
Astrovirus 2 [GenBank: L13745]; Human Astrovirus 3 [GenBank: AAD17224];
Human Astrovirus 4 [GenBank: DQ070852]; Human Astrovirus 5 [GenBank:
DQ028633]; Human Astrovirus 6 [EMBL: CAA86616]; Human Astrovirus 7
[Gen Bank: AAK31913]; Human Astrovirus 8 [GenBank: AF260508]; Turkey
Astrovirus 1 [GenBank: Y15936]; Turkey Astrovirus 2 [GenBank: NC_005790];
Turkey Astrovirus 3 [GenBank: AY769616]; Chicken Astrovirus [GenBank:
NC_003790]; Ovine Astrovirus [GenBank: NC_002469]; Mink Astrovirus
[GenBank: NC_004579], Astrovirus MLB1 [GenBank: NC_011400], and Bat
Astrovirus [GenBank: EU847155].

Real Time assay:
The real-time RT-PCR assay was performed using the SuperScriptTM III OneStep RT-PCR kit (Invitrogen Corp., Carlsbad, CA) and the Mx4000® system
(Stratagene, La Jolla, CA). Each 50ul reaction mixture contained 900 pmol
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of forward primer (5' TAT CCA TAG TTG TGG ATA TTT GTC CA 3' ), 1000
pmol of reverse primer (5' TGT CTT AGG GGA GAC TTG CAA A 3' ) and 100
pmol of probe (5' TT CC CCCT GTC CTG GAT TGT CAC TTC 3'), 1x buffer,
6.0 mM MgSO4 (final concentration), 20 units of RNase inhibitor, a 5 µl
aliquot of RNA extracts, and 1 unit of SuperScript III RT/Platinum Taq Mix.
Water was added to achieve a final volume of 50 µl. The RT-PCR reaction
mixture was incubated at 60ºC for 1 minute for denaturing, 50ºC for 30
minutes (for RT), 94ºC for 2 minutes (for hot start), then 40 cycles at 94ºC for
15 seconds; 55ºC for 30 seconds; 72ºC for 30 seconds and a final extension
at 72ºC for 7 minutes. Fluorescence measurements were taken and the
threshold cycle (CT) value for each sample was calculated by
determining the point at which fluorescence exceeded a threshold limit
set at the mean plus 10 standard deviations above the baseline.

Semi-nested RT-PCR assay:
The first round RT-PCR in the semi-nested assay was performed according
to the protocol described previously [165] using forward primer (5' AGG
GGT CGC TGG GAG TTT G 3') and reverse primer (5' GTC TAT TGT TTT GGG
CGT CTG C 3'). The 2nd round PCR in the semi-nested assay PCR assay in
50ul reaction mixture contained 1x buffer (Platinum Taq kit; Invitrogen), 2
mM MgCI2, 200uM (each) of deoxynucleoside triphosphates, 50 pmol
(each) of forward primer (5' AGG GGT CGC TGG GAG TTT G 3' ) and
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reverse primer (5' CGG GGG TGG TGC GAC AT 3') 1 U Platinum Taq, one
2-ul aliquot from the first reaction, and water to achieve a final volume of
50 ul. The mixture was first heated to 94°C for 2 min. The cycling conditions
were 40 cycles with the same conditions as for the first amplification: 94°C
for 15 s, primer annealing at 55°C for 30 s, and 72°C for 30 s. A final
extension was carried out at 72°C for 7 min. The final seminested PCR
products were visualized by UV light after electrophoresis on a 2% agarose
gel containing 0.5 ug/ml ethidium bromide in 0.5 x Tris-borate buffer.
Amplicons from the final round of PCR were purified using the QIAquick
PCR purification kit (Qiagen, Inc., Valencia, CA). Both strands of the
amplicons were sequenced with a BigDye Terminators v3.1 ready reaction
cycle sequencing kit as described above.

ACKNOWLEDGMENTS

This work was supported in part by National Institutes of Health grant 2 U54
AI057160-06 to the Midwest Regional Center of Excellence for Biodefense
and Emerging Infectious Diseases Research. DW holds an Investigators in
the Pathogenesis of Infectious Disease Award from the Burroughs
Wellcome Fund.

- - 119 - -

Chapter 6: Conclusions
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In the developed world, diarrhea is not commonly thought of as a
major health concern. However, diarrhea is a yet unsolved problem given
that it is still the third leading cause of death due to an infectious disease.
Since ~40% of all cases are of unknown etiology, there is a major gap in
our understanding of the causes of diarrhea. Not fully understanding the
problem

hinders

the

development

of

comprehensive

tactics

for

prevention and treatment of diarrhea. My doctoral thesis work was aimed
at addressing the existing gap in knowledge and has served to make
important strides towards potentially closing this gap.
Currently,

there

is

building

excitement

about

the

Human

Microbiome Project which is a National Institutes of Health multi-institute
iniative to use mass sequencing to determine the microbial populations
associated with humans at various sites of the body. However, this is a
new found excitement. Few people were talking about metagenomic
analysis of human-associated microbial communities at the time in which
this thesis work began. While some groups had examined the spectrum of
viruses present in stools from healthy adults, and that is in part what the
Human Microbiome Project proposes to do further, no one had previously
examined what spectrum of viruses can be found in diarrhea samples. My
initial analysis of 12 diarrheal stools was therefore the first snapshot of the
diarrhea virome. This analysis revealed that the spectrum of viruses
associated with diarrhea is highly varied in terms of the families of viruses
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found in a given sample, the numbers of different viruses in a given
sample, and the relative abundance of viruses in the samples. This
suggests that the complexity of the human diarrhea virome is quite
complex and highlights the difficulty of assessing the role of an individual
virus in causing diarrhea when there is a complex mixture of viruses
present in a sample.
Perhaps

the

most

exciting

finding

that came

out of

the

metagenomic analysis of the first 12 diarrhea samples was that there were
many novel viruses present in the samples. The identification of multiple
novel viruses in just a small random sampling of diarrhea specimens
provides confidence that there are still many unknown viruses to be
discovered and provides further encouragement to continue searching
for them.
One of the novel viruses that was identified belongs to the family
Nodaviridae. The identification of this virus perfectly exemplifies the
possibility for paradigm shifting discoveries. Nodaviruses are known to
infect fish and insects, but do not naturally infect humans. The
identification of a novel nodavirus in a human diarrhea specimen presents
the possibility that the virus infects humans. There are other explanations
though. For example, it is possible that the virus was derived from some
dietary source, perhaps an infected fish, and was simply passed through
the gastrointestinal tract. However, if it can be demonstrated that this
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novel nodavirus does infect humans, it would be an exciting finding since
this virus would be the first nodavirus known to infect humans. Discoveries
of viruses like this one points out the need to have an unbiased approach
to search for novel viruses and furthermore for thinking about what the
potential causes of diarrhea might be. Of course, much more work needs
to be done in order to discern between the possible explanations for the
nodavirus’ presence in the diarrhea sample.
The most promising discovery of the initial metagenomic analysis
was that of a novel astrovirus, AstV-MLB1, in an Australian diarrhea
specimen. Phylogenetic analysis revealed that AstV-MLB1 is highly distinct
from any of the known astroviruses, including the known human
astroviruses, confirming that AstV-MLB1 is in fact a highly divergent, novel
astrovirus. Given that astroviruses are known to infect humans and that
they typically cause diarrhea in their hosts it is easy to believe that this
astrovirus could also cause diarrhea in humans, however that has yet to
be proven. The detection of AstV-MLB1 in additional diarrhea specimens
from Saint Louis is the first report examining the prevalence of AstV-MLB1
and the first detection of AstV-MLB1 outside of Australia. Detection of
AstV-MLB1 on two continents suggests that the virus may be globally
widespread, suggesting that if it is shown to be a human pathogen it may
affect a wide distribution of people around the world.
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The identification of MLB1 was followed by the identification of yet
another highly divergent, novel astrovirus. This astrovirus, AstV-VA1, was
found in 3/5 samples from a gastroenteritis outbreak. The identification of
AstV-VA1 in association with a diarrhea outbreak presents a very strong
possibility that this astrovirus is in fact associated with diarrhea.
While astroviruses are known to cause diarrhea, they have generally
been associated with at most 10% of both sporadic and outbreak cases
of acute diarrhea. The identification of two novel astroviruses in human
diarrhea samples hints that astroviruses may have a larger role in causing
human diarrhea than previously believed. There are 8 known human
astroviruses which are all very closely genetically related. Following that
example, it is possible that each of these viruses represents a whole new
cluster of astroviruses. One could furthermore hypothesize that these novel
astroviruses may eventually be shown to cause diarrhea and allowing us
to begin to close the gap in our understanding of the causes of diarrhea.
Significant technological developments within recent years have
greatly enhanced our ability to detect both known and novel viruses as
evidenced by the work presented in this dissertation as well as work done
by others.

Continuing evolution of these technologies will certainly lead

to further increases in this arena.

Critically, while the identification of

novel viruses is becoming increasingly more facile, the discovery is merely
the introductory chapter into each virus’ story.
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For example, with each

new virus identified, there are a host of questions that arise regarding
each virus’ tropism, epidemiology, and potential link to disease.

To

answer these questions will require many years of further investigation,
using myriad tools of biology, virology and medicine.
The scientific questions that need to be addressed for each virus are
initially all the same. The major questions for both AstV-MLB1 and AstV-VA1
are whether they are actually human pathogens and if so, whether they
do in fact cause diarrhea. These questions are difficult to answer short of
doing human infection trials. The founding principles for demonstrating
microbial pathogenesis are based on satisfying Kochs postulates. Today
we know that Kochs postulates cannot always be satisfied for every
pathogen. The reasons for this can vary from ethical considerations of
carrying out human experiments to the fact that not all pathogens can
be cultured, which is a requirement for satisfying the postulates.
Culturing of these novel viruses may present a major challenge for
future research investigations. Since traditional virus discovery methods
relied heavily on the ability to culture viruses, one might argue that these
viruses are unlikely to grow well under standard culturing conditions or else
they would have already been discovered. There are many important
humans pathogens that have proven difficult to culture such as human
noroviruses and hepatitis C virus. For these viruses, significant effort has
been exerted since their discoveries in trying to get them to grow in the
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laboratory. It might be the case that significant creativity as well as a lot of
trial and error will be required to establish culturing conditions for these
novel astroviruses. This is a very important direction for future research on
these viruses because having a culturable virus makes exploring other
scientific questions easier and also facilities production of vaccines and is
useful for other translational applications.
Kochs first postulate is that an organism must be found in all disease
cases and in no healthy cases in order for it to be considered a pathogen.
Again, we know that these absolutes are not always true, especially when
considering a polymicrobial disease like diarrhea. There are many factors
such as the host immune system, co-infecting microorganisms, and
environmental factors that are speculated to be involved in viral
pathogenesis, but the extent of how these factors affect different viruses is
not well understood. However, if AstV-MLB1 and AstV-VA1 can be
statistically associated with diarrhea cases rather than healthy cases, then
that will provide compelling evidence to say that these viruses cause
diarrhea. Therefore, screening large cohorts of case-controlled diarrhea
specimens is also an essential next step for the progression of research on
these viruses.
Finally, some of the best evidence to demonstrate that these viruses
infect humans is seroconversion upon exposure to the virus. It is assumed
that the generation of antibodies implies that the virus actually infected
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the host as opposed to having been passed through the gastrointestinal
tract. Again since there are ethical concerns for doing human
experiments with novel viruses about which very little is known, the best
proxy for directly monitoring seroconversion is to examining existing
immunity to these viruses in the general population. Seroprevalence
studies can give us some information about how common these viruses
are in the human population and potentially at what age people are
frequently exposed to them.
Historically, it has been postulated that the identification of novel
viruses in a given specimen or syndrome is the rate-limiting step in
addressing the question of disease causality.

With the advent of new

technologies, a shift has occurred such that in many instances, the ratelimiting step is no longer discovery but understanding the biological
relevance and impact of newly discovered viruses. The application of
unbiased, culture independent discovery methods has already yielded
many fruit in the form of new viruses, which are likely to be just the tip of
the proverbial iceberg. Undoubtedly many additional new viruses will be
uncovered in the upcoming years, thereby providing new substrates for
investigation and understanding of virology, virus host interactions, virusenvironment interactions, and of course disease pathogenesis.
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